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ABSTRACT 
 
Obesity is a world-wide health problem. The increasing incidence of this 
pathology among women of reproductive age and children highlights the main 
question of the role played by maternal obesity in setting up a state of individual 
susceptibility to metabolic disorders in the adult offspring. A growing body of 
evidence suggests that maternal obesity and maternal adiposity, per se, are 
associated with adverse acute maternal and neonatal outcomes. It has been 
stated that maternal obesity and, more in general, maternal over-nutrition, such 
as maternal feeding a diet rich in fats (high-fat diet - HFD), are strongly 
associated with a raised offspring susceptibility to cardiovascular disease 
(CVD) and metabolic impairment, such as hyperglycaemia and 
hyperinsulinemia, type 2 diabetes (T2D) and obesity at adulthood. Obesity is a 
pathophysiological condition characterized by a low-grade chronic 
inflammation which contributes to the mechanism for obesity-related metabolic 
syndrome, insulin resistance (IR) and diabetes. Increased physiological levels of 
oxidative stress (OS) may be causatively linked to the development and 
progression of complications associated to obesity and over-nutritional state. 
Clinical as well as experimental studies support the theory of the 
“developmental origins of health and disease” according to which the prenatal 
environmental adversities may exert lifelong consequences by programming the 
offspring’s development. However, a comprehensive and multi-levels 
characterization of the long-term impact of maternal HFD is still lacking. In 
addition, very few studies have paid attention to the long-term effects of 
exposure to a maternal HFD during the in utero life only. The general aim of 
the work presented in this thesis was to evaluate the impact of maternal HFD 
both on mother and offspring in a long-term perspective and to study the effects 
of metabolic disturbances occurring in a sensitive time window of the individual 
life (i.e. fetal development and pregnancy) on the stress response, as well as on 
the metabolic and emotional profiles. We also aimed at investigating the 
interaction between an early metabolic stimulus (maternal HFD) and a 
physiological condition of reduced OS.  
In particular, in Chapter 2, we report about the long-term effects of 
prenatal exposure to maternal HFD assessing the metabolic, neuroendocrine as 
well as the behavioral profile of young adult offspring in a transgenic mouse 
model characterized by reduced oxidative stress, the p66Shc-/-.  
In Chapter 3 we report the effects of a prenatal exposure to N-acetyl-
cysteine, a drug characterized by remarkable antioxidant properties, to thwart 
the physiological response to maternal HFD in utero. These studies relied on the 
assessment of a physiological (Chapter 2) or pharmacological (Chapter 3) 
condition of reduced OS able to represent a protective condition toward the 
maternal HFD. 
Chapter 4 describes the effects of HFD feeding before and during 
pregnancy on the neuroendocrine and behavioral profile of dams in the perinatal 
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period. In addition, in this chapter we propose to investigate the potential role of 
HFD as a metabolic stressor for the mother with a negative impact for the 
developing fetus. 
Results are discussed considering the impact of HFD feeding during 
pregnancy on the dam and the possible consequences on the offspring at 
multiple levels (behavioral, metabolic and endocrine). Particular attention has 
been paid to a physiological or pharmacological condition of reduced OS as a 
potential protective factor. Results obtained in this thesis might drive the 
attention on selected markers useful to detect potential unhealthy states and to 
develop future preventive strategies as well as pharmacological therapies to 
limit the effects associated to maternal HFD. 
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1. GENERAL INTRODUCTION 
 
1.1. RELEVANCE OF OBESITY IN MODERN SOCIETY 
 
Obesity is one of the major health care issues of the 21st century reaching 
epidemic levels (Ezzati et al., 2005; Hurt et al., 2010). It has been described as a 
metabolically inflexible state defined as impaired regulatory response to 
metabolic challenges such as fasting, exercise and overfeeding (Storlien et al., 
2004; Phielix and Mensink, 2008; Corpeleijn et al., 2009). Obesity is associated 
with a markedly elevated risk of type 2 diabetes (T2D) (Pirkola et al., 2010a; 
Pirkola et al., 2010b), metabolic impairment, such as hyperglycaemia, 
hyperinsulinaemia and hyperleptinaemia (Weissgerber et al., 2006), in addition 
to raised blood pressure and impaired cardiovascular function (Khan et al., 
2003; Khan et al., 2005), thus resulting in increased risk for cardiovascular 
disease (CVD). Besides representing a problem in developed countries, 
overweight and obesity are dramatically increasing in the population of low- 
and middle income, especially in urban areas (Han et al., 2010; Nelson et al., 
2010) and are expected to almost double in the next decade (Kim et al., 2007). 
In addition to the general incidence, obesity is a major public health concern for 
women of reproductive age, for which has been registered an increasing global 
prevalence (WHO, 2000). Currently, 13% of 21- to 30-year-old women and 
22% of 31- to 40-year-old women in the UK are obese, with figures estimated 
to rise to 30 and 47% respectively by 2050 (FORESIGHT, 2001; Mitchell and 
Shaw, 2014). 
 
1.1.1. Maternal obesity is a predisposing factor for the incidence of obesity 
The overall increase in overweight and obesity naturally leads to a disturbing 
increase in the incidence of weight and metabolic problems in pregnant women. 
Maternal obesity is indeed associated with adverse acute maternal and neonatal 
outcomes and the long-term consequences of maternal obesity in pregnancy 
have large implications both for the mother and her offspring (Martorell et al., 
2001; Boney et al., 2005; Catalano and Ehrenberg, 2006; Wardle et al., 2008; 
Pirkola et al., 2010a; Pirkola et al., 2010b; Dabelea and Crume, 2011). Actually, 
a particularly alarming increasing rate of obesity has also been registered among 
children and adolescents, thus driving particular attention on the understanding 
of the underlying causes. A central dogma to obesity development is that the 
individual environment is crucial and determines lifestyle choice resulting in an 
energy imbalance so that caloric intake exceeds caloric expenditure. In this 
perspective, a sedentary lifestyle and wrong dietary habits can worsen the 
situation, especially in individuals who already have a tendency to obesity (Hill 
and Peters, 1998; Swinburn et al., 2004). In addition, despite the relevance of 
lifestyle, the identification of familial risk factors for obesity (Lee et al., 1997) 
is suggestive of genetic factors contributing to obesity development (Wardle et 
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al., 2008). Notwithstanding the recognized role played by genetic factors in the 
development of obesity, these alone cannot account for the tripling in the 
prevalence of overweight and obesity over the past 3 decades (Ogden et al., 
2006). It is more likely that environment and genes are not acting independently 
and that gene-environment interactions, also through epigenetic modifications 
of the genome, are driving the rapid increased prevalence of obesity. To this 
regard, it has been suggested that epigenetic mechanisms acquired in early life 
have phenotypic consequences later in development through their role on 
transcriptional regulation with relevance to the developmental origins of 
diseases, including obesity (Gluckman and Hanson, 2008; Relton et al., 2012). 
Changes both in epigenomic patterns and expression of genes involved in the 
regulation of energy homeostasis are indeed recognized as key mechanisms 
resulting in phenotypic long-lasting individual differences and thus in metabolic 
imprinting of permanent alterations. 
 
1.1.2. In utero environment programs metabolic development during life 
Epidemiological and clinical studies as well as experimental animal work have 
introduced the concept of “developmental origins of health and disease”. This 
theory supports the hypothesis that prenatal environmental adversities may exert 
lifelong consequences by programming the offspring’s cells, tissues, organs, 
their structure and function. 
Maternal obesity is associated with 2-fold higher incidence of heavier 
newborns than in non-obese women (Castro and Avina, 2002) and, in turn, 
fetuses of obese mothers have higher percentage of body fat than fetuses of lean 
mothers. This could results from imprinting of maternal genes that influence 
energy balance, but a more widely accepted possibility is that the predisposition 
is mediated by the in utero environment a developing fetus of an obese woman 
is exposed to (Wardle et al., 2008; Drake and Reynolds, 2010; Nelson et al., 
2010). Studies suggest that changes in the intrauterine environment of obese 
women can cause metabolic adaptations in the fetuses, with immediate or late 
consequences (King, 2006; Nelson et al., 2010).  
Maternal obesity has no major influence on body weight of the 
offspring, similar to the effect of high-fat diet during pregnancy, suggesting that 
maternal adiposity per se is necessary for the programming effect that 
predisposes the offspring to obesity (White et al., 2009). This is also supported 
by further evidence suggesting that maternal body composition per se is a 
driving factor in offspring adiposity (Sacks et al., 2006). Evidence from animal 
studies supports the hypothesis that the core features underlying obesity result 
from the obesogenic environment experienced in utero rather than pure genetic 
factors. However, the precise obesogenic environmental factors and the 
underlying mechanisms that mediate these effects are largely unknown. Several 
mechanisms may explain the associations between exposure to obesity in utero 
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and long-term metabolic outcomes in the offspring, i.e., genetic and lifestyle 
factors as well as specific intrauterine effects.  
One developmental pathway to obesity is the fetal over-nutrition 
pathway (Yajnik, 2009), reflecting the effects of hyperinsulinaemia and other 
factors during fetal life. This creates conditions for later pathophysiological 
effects of an early obesogenic environment. Beyond increased risk of metabolic 
disturbances, evidence shows adverse effects of maternal HFD on offspring’s 
brain development, with consequences on affective behavior and cognition 
(Sullivan et al., 2011). Specifically, animal studies have identified alterations in 
hippocampal and hypothalamic regions as well as in serotonergic, dopaminergic 
and opioid neurotransmitter systems, resulting in changes of cognitive and 
affective behaviors in offspring born to obese mothers (Naef et al., 2008; 
Walker et al., 2008; Bilbo and Tsang, 2010; Sullivan et al., 2010; Tozuka et al., 
2010; Vucetic et al., 2010; Naef et al., 2011; Wright et al., 2011). 
 
1.2. DERANGEMENTS ASSOCIATED TO MATERNAL OBESITY 
 
Alterations in maternal metabolism may contribute to the over-nutrition 
pathway (Schaefer-Graf et al., 2008). Lipids play a key role in adipocytes 
differentiation, thus, increased transfer of free fatty acids might affect fetal 
adiposity by influencing the number, size or activity of fetal adipocytes. 
 
1.2.1. Metabolic regulation and fetal metabolic programming 
Adipose tissue is recognized as a major endocrine and secretory organ, releasing 
a wide range of protein factors and signals, such as leptin, that is directly 
involved in the regulation of energy balance by a direct action on the 
hypothalamus (Friedman and Halaas, 1998; Minokoshi et al., 2004), in addition 
to peripheral signaling (Muoio et al., 1997; Minokoshi et al., 2002). In the 
hypothalamus leptin stimulates the activation of specific pathways resulting in 
increased energy expenditure and decreased body weight and food intake (Gao 
and Horvath, 2007). In obese humans there is a failure of this hormone to exert 
the appropriate effects, reflective of a leptin resistant state (Liuzzi et al., 1999; 
Enriori et al., 2007), a key component of obesity. Progression to this state has 
been shown to involve firstly a gain in adiposity while still retaining responses 
to peripherally administered leptin, followed by a loss of peripheral leptin 
responsiveness and, finally, a complete resistance to both peripherally and 
centrally administered leptin (El-Haschimi et al., 2000). During obesity, there is 
an acquired and reversible reduction in the transport of leptin across the blood 
brain barrier with intraperitoneal leptin administration (Banks and Farrell, 
2003). There is also a failure within hypothalamic leptin signalling pathways, 
with a loss of effectiveness of centrally administered leptin on the inhibition of 
food intake and stimulation of energy expenditure (El-Haschimi et al., 2000; 
Munzberg and Myers, 2005). However, a preservation of the cardiovascular 
 8 
effects of leptin is seen, such that obesity and its associated hyperleptinemic 
state induces further increases in blood pressure, suggesting that ‘selective 
leptin resistance’ is an important component of the metabolic syndrome 
(Correia et al., 2002; Rahmouni et al., 2005).  
In addition to the role that leptin plays in adult life, its fundamental 
action has been also recognized in the establishment of hypothalamic circuitry 
during the earliest stage of life (Bouret and Simerly, 2006). Prior and colleagues 
found that offspring from HFD-fed dams exhibits an altered hypothalamic 
sensitivity to leptin, suggesting that metabolic alterations occurring in a 
susceptible time window for the developing organism impair central 
mechanisms regulating leptin secretion at adulthood (Prior et al., 2013).  
Obesity is typically associated with insulin resistance (IR). Insulin is a 
peptide hormone that regulates the metabolism of carbohydrates and fats by 
promoting the absorption of glucose from the blood to skeletal muscles and fat 
tissue. In healthy conditions, insulin is provided within the body in a constant 
proportion to remove excess glucose from the blood, which otherwise would be 
toxic. In obese subjects, the IR state leads to hyperinsulinemia. In women, this 
trait seems to confer, in addition to an increased risk for hypertension, central 
fat accumulation and inflammation, as well as adverse pregnancy outcomes 
(Catalano, 2010). In addition, it is important to note that IR in the mother 
predicts the size (Das et al., 2010) and the degree of IR in the fetus (Catalano et 
al., 2009). Maternal hyperinsulinemia is associated with increased gestational 
weight gain and weight retention postpartum (Scholl and Chen, 2002). During 
pregnancy it is usually reported an increase in the mass of visceral fat both in 
lean and, to a greater extent, in obese women. In the latter case, an increase in 
fat mass is commonly associated with metabolic-related diseases. Animal 
studies have shown that the offspring of female mice fed a diet-induced obesity 
develop IR, hypertension (Samuelsson et al., 2008), adiposity and hyperphagia. 
Actually, Murabayashi and co-workers (Murabayashi et al., 2013) demonstrated 
that maternal HFD in mice causes inflammatory changes in the adipose tissue of 
the offspring. Studies in sheep, fed an obesogenic diet, documented tissue-
specific defects in the insulin-signaling cascade in the fetal myocardium and an 
impaired response to workload stress in the heart (Wang et al., 2010). 
 
1.2.2. Hypothalamic-pituitary-adrenal axis activation 
Stress is commonly defined as a state of threatened homeostasis (Chrousos, 
1998) by either endogenous or exogenous factors which induce specific 
response mechanisms, most prominently the sympathetic nervous system and 
the hypothalamic-pituitary-adrenal (HPA) axis, which result in a series of neural 
and endocrine adaptations collectively known as the stress response. While the 
adaptive response to acute stressors is advantageous for survival, periods of 
chronic stress or stressful life events may be maladaptive and have been 
associated with a variety of pathological conditions (Charney and Manji, 2004; 
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Rosengren et al., 2004; de Kloet et al., 2005; Abraham et al., 2007; Dallman, 
2010). 
A large body of epidemiological evidence indicates a strong link 
between chronic stress, especially social stress, and metabolic disturbances 
(Tamashiro, 2011). Specifically, chronic stress represents a major risk factor for 
the development of abdominal obesity and the metabolic syndrome, i.e. a cluster 
of metabolic factors that increase the risk to develop CVD and T2D (Rosengren 
et al., 2004; Chandola et al., 2006; Branth et al., 2007). Indeed, Bartolomucci 
and colleagues demonstrated how chronic psychosocial stress represents a 
model of stress induced weight gain and vulnerability to obesity (Bartolomucci 
et al., 2009). Animal models provide further evidence for an interaction between 
the stress response and energy balance, suggesting that exposure to stress affects 
the feeding behavior by regulating caloric intake and body weight alterations 
(Rosengren et al., 2004; Chandola et al., 2006; Branth et al., 2007; Foster et al., 
2009; Tamashiro, 2011).  
Strong evidences report the link between stress or glucocorticoids 
(GCs) exposure to later development features of the metabolic syndrome 
(Lindsay et al., 1996; Nyirenda et al., 1998). During stress, chow intake 
decreases but intake of lard and sucrose does not. In addition, Dallman and 
colleagues suggest that palatability signals and neural signals from fat stores act 
on the brain to reduce activity in the central stress response system (Dallman et 
al., 2007). A wide literature demonstrates the involvement of the same neural 
pathways both in the regulation of the stress responses and in maintaining of the 
metabolic homeostasis. However, to date relatively little research has focused 
on the long-term effects of maternal HFD on the offspring’s stress response 
(Nieuwenhuizen and Rutters, 2008) and the molecular basis underlying this 
relationship remain largely unknown. Nevertheless, the effects of maternal 
nutritional status, during gestation and lactation, to increase the response to 
stress is recognized both in mother and, more interestingly, in the offspring. 
Several data have been reported to this regard demonstrating alterations in HPA 
axis responsiveness after an acute stressor in neonates and pre-pubertal rats 
exposed to maternal HFD (Trottier et al., 1998). Moreover, it has been shown 
that the neonatal HPA axis is sensitive to metabolic signals, including glucose 
and ghrelin (Schmidt et al., 2006), suggesting that changes in the level of 
metabolic signals resulting from changes in maternal diet may influence the 
development of the neonate’s HPA axis response. The close communication 
between metabolic signals and neuroendocrine response is further supported by 
studies reporting that prenatal stress or GCs exposure in rodents lead to features 
associated with the metabolic syndrome, such as hypertension and 
hyperglycaemia (Lindsay et al., 1996; Nyirenda et al., 1998; Mueller and Bale, 
2006; Tamashiro et al., 2009). Moreover, the hormonal mediators of the stress 
response (GCs and catecholamines) are important modulators of metabolism 
and cardiocirculatory function (Mastorci et al., 2009). 
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1.2.2.1. Glucocorticoids as mediators of fetal programming effects 
GCs are steroid hormones with diverse roles including the regulation of stress 
responses, glucose homeostasis and immune function, also exerting multiple 
effects during fetal development, especially in the promotion of tissue 
maturation and function. 
Briefly, GCs, also defined “stress hormones”, are produced by adrenal 
cortex as the final result of the HPA axis activation in response to internal or 
external stressful stimuli. The response to stress starts after stimulation of 
paraventricular nucleus in the hypothalamus and the consequent release of 
corticotropin releasing hormone (CRH), a key mediator of many aspects related 
to stress (Koob, 1999). CRH stimulate the anterior pituitary gland-release of 
adrenocorticotropic hormone (ACTH), which in turn lastly stimulate the adrenal 
glands.  
Alterations in the central and peripheral sensitivity to GCs have been 
described in both humans and animal models of obesity. Increased secretion of 
GCs by adrenals glands in response to specific stimuli, due either to a centrally 
hyperactivity of the HPA axis or reduced negative feedback response, altered 
tissue levels of GCs receptors (GRs) and changes in peripheral GCs metabolism 
have all been shown to contribute to hypertension, hyperglycemia and impaired 
insulin sensitivity (Jessop et al., 2001). 
The developing fetus is maintained in a low GCs environment to protect 
it against the potent effects of GCs that accelerate fetal organ maturation in a 
tradeoff against overall growth. During in utero development, the activities of 
specific placental enzymes provide a barrier that regulates the physiological 
maternal GCs levels functional to fetal tissue maturation (Benediktsson et al., 
1997). More in detail, two steroid enzymes are involved in the maintenance of 
the GCs gradient between mother and fetus: the 11β-hydroxysteroid 
dehydrogenase (11β-HSD) type 1 and type 2. Briefly, the 11β-HSD type 1 
enzyme activates the maternal circulating GCs to the fetus, while the reverse 
reaction is driven by the 11β-HSD type 2 isoform, that rapidly converts 
physiologically active GCs to inert forms (Seckl et al., 2004; Grino, 2005). 
Human and rodent fetuses show a developmental switch from 11β-HSD type 2 
in early and mid-gestation (Murphy, 1978; Brown et al., 1996; Condon et al., 
1998) to 11 β-HSD type 1 activity in late gestation (Murphy, 1978; Thompson 
et al., 2004). The timing of this “switch” is functional to the right fetal 
development. In accordance with the largely antiproliferative and pro-
differentiation effects of GCs and their maturational role in preparation for birth 
(Fowden et al., 1998), 11β-HSD type 2 is expressed in immature cells, 
protecting tissues from inappropriate GC exposure during development 
(Holmes et al., 2006; Wyrwoll et al., 2010), whereas 11β-HSD type 1 is 
expressed only from late development, apparently amplifying GC maturational 
effects on fetal tissues.  
 11 
It has been hypothesized that variations in the expression or in the 
activity of the fetus-placental 11β-HSD type 2 enzyme may underlie prenatal 
GCs programming (Edwards et al., 1993). The observation that placental 11β-
HSD type 2 enzyme activity correlates directly with birth weight in rodent 
(Benediktsson et al., 1993) and in most human studies (Stewart et al., 1995; 
Murphy et al., 2002; Kajantie et al., 2003; Aufdenblatten et al., 2009), suggests 
that normal variation in fetal exposure to maternal GCs has an impact on fetal 
growth. More interestingly, preclinical and clinical studies suggest that 
maternal-mediated metabolic intervention during fetal life affects the enzymatic 
activity of 11β-HSD type 2 with subsequent alteration of fetal exposure to 
maternal GCs. In particular, in rat models of maternal malnutrition, the feeding 
of a calorie restricted or low-protein diet reduces placental levels of 11β-HSD 
type 2 enzyme and offspring are born of a lower birth weight and present 
hypertension in later life (Bandyopadhyay and Medrano, 2003; Zeugmann et al., 
2010). As well as in clinical studies, protein-restricted diet throughout gestation 
caused an increase in maternal and fetal GC levels (Lesage et al., 2001; Guzman 
et al., 2006), together with a decrease in placental 11β-HSD type 2 enzymatic 
activity (Langley-Evans et al., 1996; Bertram et al., 2001; Stocker et al., 2004). 
These results suggest that there are common mechanisms underpinning both 
nutritional and GCs developmental programming. 
 
1.2.3. Offsprings’ emotional phenotype 
Despite the programming effect of maternal HFD on metabolism and metabolic 
disorders, little is known thus far about its possible consequences on the 
psychological/behavioral development of the offspring. Actually, relatively 
little attention has been paid so far to the impact of overfeeding during 
pregnancy and the effect it might have on the emotional behavior, such as 
anxious behavior, depression and, more in general, altered emotional responses 
and cognitive deficits of the offspring later in life. Indeed, anxiety and 
depression are amongst the most commonly found comorbid disorders of 
obesity in humans following diabetes and CVD and thus represent a major 
concern in today’s healthcare system (Luppino et al., 2010). It is unclear 
whether the natural history of stress-induced effects on behaviors related to 
mood and anxiety are coincident with alterations observed in food intake. 
Despite behavior being a key readout for stress induced changes in animal 
models (Cryan and Holmes, 2005; Lutter et al., 2008; Chuang et al., 2010; 
Vidal et al., 2011), there is a paucity of behavioral studies on the feedback 
effects induced by ingestion of highly caloric diets or diet-induced obesity on 
the stress response (Pecoraro et al., 2004). 
 
1.2.4. Oxidative stress 
Oxidative stress (OS) is a state characterizing biological systems in aerobic 
conditions derived from an imbalance between pro-oxidative and anti-oxidative 
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molecules where the oxidants override defensive systems. Oxidative molecules, 
namely Reactive Oxygen Species (ROS), are produced primarily by the 
physiological metabolism of oxygen (O2) in cells (Kakkar and Singh, 2007) but 
also environmental stimuli, such as cytokines, ultraviolet radiation, 
chemotherapeutic agents, hyperthermia and even growth factors, might 
contribute to their generation shifting the normal cellular red-ox balance into a 
state of OS potentially leading to diabetes, ischemia/reperfusion, to mention 
only a few (Dhalla et al., 2000; Finkel and Holbrook, 2000; Sayre et al., 2001; 
Jenner, 2003; Dalle-Donne et al., 2006).  
Elevated OS, in addition to be involved in a variety of pathological 
conditions, such as inflammation, atherosclerosis, cancer and several age-
related neurodegenerative disorders (Finch and Marchalonis, 1996; O'Banion 
and Finch, 1996; Hensley et al., 1999; Finkel and Holbrook, 2000; Zhu et al., 
2001a; Zhu et al., 2001b), is also a contributing factor to obesity (Itabe, 2012). 
As already previously mentioned, a pathophysiological feature of obesity is the 
low-grade chronic inflammation in adipose tissue that secretes a number of 
inflammatory markers, some of which implicated in pathologies associated with 
obesity (Pouliot et al., 1994; Foundation, 2005; Trayhurn, 2005). In obese 
patients, subclinical inflammation has been found to correlate with markers of 
OS in adipose tissue and this may be the mechanism for obesity-related 
metabolic syndrome, IR and diabetes mellitus. Furthermore, both OS and low-
grade inflammation may be causatively linked to the development, progression 
and complications of diabetes in obese patients. 
 
1.3. RELEVANCE OF ANIMAL STUDIES 
 
Although there are obvious limitations to the extrapolation of data resulting 
from research conducted in animal studies to human health, the use of animal 
models allows for a comprehensive analysis of the offspring and to dissect out 
discrete periods of offspring development for a mechanistic understanding. In 
addition, basic research conducted in rodents can allow differentiating between 
genetic and environmental factors involved in the development of obesity, in 
addition to studying the interaction between the two factors. Animal models 
have proven invaluable in interrogation of associations between maternal diet 
and offspring phenotype (Levin, 2006; Schmidt et al., 2006), providing the 
ability to study the long-term consequences of maternal diet or prenatal stress 
on offspring while allowing to control variables that human studies do not 
afford. These studies support the hypothesis that a diet rich in fat during 
pregnancy can transmit a propensity for adiposity, glucose intolerance and 
cardiovascular dysfunction to the offspring. Actually, reported results are 
sometimes quite controversial. In rodents, some studies have shown that 
prenatal obesity has been associated with impaired mammary gland 
development, thus compromising lactation and pups’ growth (Rolls et al., 1980; 
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Rolls et al., 1986; Rasmussen et al., 1998; Flint et al., 2005), while others have 
shown increased pup growth (Fisher et al. 1992; Gorski et al., 2006).  
It should be noted that these results are more commonly reported in 
male offspring, although many studies observe comparative effects in female 
littermates (Bayol et al., 2007). Most of these studies suggest that sex 
differences may be of interest for future investigations in which disturbed 
glucose homeostasis is a primary outcome.  
Rodent models have also been extensively used to study differential 
susceptibility between individuals to diet-induced obesity (DIO). These models 
have provided information on the rate of body weight changes induced by 
feeding to such a diet and have been also able to reveal differences in terms of 
susceptibility to DIO, both between different animal strains (Prpic et al., 2003) 
and even within the same species (Levin and Sullivan, 1989; Archer et al., 
2003; Enriori et al., 2007). The C57BL/6J mouse strain is an inbred line, 
although being genetically homogeneous, it exhibits a heterogeneous response 
to high-fat feeding, with some animals developing obesity and some remaining 
lean (Burcelin et al., 2002; Collins et al., 2004). This variability in the response 
to metabolic stimuli is likely to be a function of epigenetic events caused by 
environmental, biological and social influences imposed on the dams or the 
offspring themselves during their development. All these factors resemble very 
closely the human situation, making these animal models of great use in the 
identification of pathways contributing to obesity development. 
 
1.3.1. The p66Shc-/- mouse model 
The p66Shc gene has emerged as a novel gerontogene able to affect lifespan by 
controlling OS and metabolism (Trinei et al., 2009). P66Shc is peculiar protein 
acting specifically in the mitochondrion as a red-ox enzyme that generates H2O2 
to trigger mitochondrial swelling and apoptosis (Giorgio et al., 2005). In the last 
decade, studies performed on p66Shc knock-out (KO) mice have indicated that 
this gene is a crucial regulator of ROS levels and that it is involved in age-
related dysfunctions. Notably, among ROS, H2O2 is the only species that is 
generated by several specific enzymes in the cell suggesting that its intracellular 
concentration is tightly regulated and may serve specific cellular functions. The 
H2O2 generated by p66Shc accounts for ∼30% of the total pool of intracellular 
H2O2 and is biologically relevant, as shown by the finding that cells and tissues 
that are derived from p66Shc KO mice accumulate significantly less OS and 
because p66Shc can induce a mitochondrial apoptotic response (Trinei et al., 
2002; Giorgio et al., 2005). p66Shc-/- mice indeed show a healthy phenotype 
characterized by greater brain and behavioral plasticity, in addition to reduced 
OS, fat accumulation and incidence of metabolic as well as cardiovascular 
pathologies (Migliaccio et al., 1999; Berry et al., 2007; Berniakovich et al., 
2008; Berry et al., 2008; Berry et al., 2010; Berry et al., 2012; Giorgio et al., 
2012). 
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Studies performed in a semi-naturalistic setting, involving exposure to 
low temperatures and food shortage, have indicated that p66Shc has been 
conserved through evolution because of its role as a ‘thrifty gene’ in energy 
metabolism. This feature, which increases the probability for survival in harsh 
natural conditions, can be deleterious when food is constantly available, as in 
westernized lifestyles, leading to fat accumulation and thus predisposing to 
metabolic disease, CVD and accelerating brain ageing (Floyd and Hensley, 
2002). 
IR and abdominal obesity, often observed in older adults, are main 
components of the metabolic syndrome, a pathological condition characterized 
by multi-organ morbidity (Folsom et al., 1993; Morley, 2008). However, a 
growing body of evidence shows that the incidence of obesity, and the often 
associated metabolic syndrome, is increasing in the young population, 
especially in western countries (Haffner and Taegtmeyer, 2003). These morbid 
conditions are accompanied by a whole metabolic unbalance with high levels of 
OS and inflammation in addition to shorter telomeres (that correlate with 
increasing BMI), overall resembling a form of precocious ageing (Fadini et al., 
2011). Furthermore, patients with metabolic syndrome are often characterized 
by a higher incidence of mood and cognitive dysfunctions than the general age-
matched population that, in turn, emerge as significant risk factors for 
aggravation of metabolic syndrome and the related health outcomes, particularly 
CVD and T2D (Engum, 2007; Goldbacher et al., 2009; Muller et al., 2010; van 
Reedt Dortland et al., 2010; Zeugmann et al., 2010; Raffaitin et al., 2011). Thus, 
overall, alterations in metabolism and body fat distribution certainly play a role 
in a vicious cycle that can precipitate even the ageing process, in addition to the 
onset of diseases (Barzilai et al., 2012). 
 
1.4. RATIONALE AND OBJECTIVES 
 
1.4.1. Current state of the art and statement of the problem 
Obesity and related co-morbidities epidemically impact modern societies, both 
in developed and in developing countries. The increasing incidence of this 
pathology among women of reproductive age and children highlight the main 
question of the role played by maternal obesity in setting up a state of individual 
susceptibility to metabolic disorders at adulthood. The literature reviewed so 
far, both in clinical and in research field, supports a raised susceptibility in the 
offspring of obese mothers to CVD and metabolic impairment, such as 
hyperglycaemia and hyperinsulinemia, T2D and obesity at adulthood. However, 
a comprehensive behavioral and endocrine characterization of the long-term 
impact of maternal HFD, combined with metabolic and stressful challenging 
conditions, is still lacking. Because of the large and complex interplay among 
the mechanisms underpinning this predisposition, we are still far from a 
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complete understanding of the mechanisms, let alone putting in place potential 
countermeasures.  
The general aim of the work presented in this thesis was to evaluate the 
impact of maternal HFD both on the mother and the offspring in a long-term 
perspective and to study the interplay of metabolic disturbances occurring in a 
sensitive time window (i.e. fetal development and pregnancy) and the stress 
system under basal conditions, as well as following an adverse challenge. We 
also aimed at investigating the interaction between an early metabolic stimulus 
(maternal HFD) and a physiological condition of reduced OS. Our hypothesis 
was that HFD feeding represents a metabolic stressful stimulus during 
pregnancy, with relevant effects on the phenotype of the mother and, 
consequently, on the phenotype of the offspring during the whole life course. 
Moreover, we hypothesize that reduced OS might result in a more efficient 
homeostatic control and better abilities to cope with changes in the internal 
milieu resulting by the maternal HFD. We propose that this analysis may 
provide information on how a reduction in the oxidative state can affect the 
physiological perception of an altered metabolic state and the molecular 
arrangements occurring during pregnancy and parturition in response to such a 
stimulus. 
 
1.4.2. Rationale of the studies 
I. Investigating the long-lasting effects of maternal high-fat feeding on the 
neuroendocrine, metabolic and behavioral phenotype of the adult offspring 
in a mouse model of reduced OS, the p66Shc knock-out mouse, paying 
particular attention to gender-specific outcomes. In addition, we aimed at 
identifying individual metabolic and/or neuroendocrine markers of 
vulnerability to metabolic and emotional disorders. The main hypothesis of 
the work was that the lack of the p66Shc gene might exert a protective role 
against the detrimental effects of maternal exposure to HFD. 
II. Develop a pharmacological model of reduced OS by means of prenatal 
administration of an antioxidant drug in the attempt to induce, in adult 
subjects, the ability to cope with metabolic challenges, represented by a 
maternal HFD, occurring during early life. Identify a time window in the 
life of the individual during which a pharmacological intervention might 
exert a preventive efficacy counteracting the consequences associated to 
maternal HFD. 
III. Investigate the effects of high-fat feeding before and during pregnancy on 
the behavioral and neuroendocrine profile of dams in the perinatal period, 
both before and after delivery, with a special focus on the effects of HFD 
on maternal behavior and on the neuronal plasticity which contributes to its 
establishment, in addition to the molecular adaptation associated with 
parturition. 
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1.4.3. Experimental approach and outline of the thesis 
In Chapter 2 and Chapter 3 are reported two studies aimed at assessing long-
term multi-levels effects associated to prenatal exposure to maternal HFD.  
Animal models of maternal over-nutrition typically involve the feeding 
of a HFD to pregnant dams. In both these studies a metabolically altered in 
utero environment has been induced by means of feeding dams a diet rich in 
fats since 10 weeks before pregnancy, and not limited to the pregnancy period 
only. It has been widely reported by several preclinical studies the hypothesis 
that a diet rich in fat during pregnancy can transmit a wide range of metabolic 
impairments to the offspring. However, while in some instances this was 
evident in offspring that had been exposed to high-fat feeding in utero only, in 
other cases the exposure was extended to the lactation period (Guo and Jen, 
1995; Buckley et al., 2005; Cerf et al., 2005). Thus, it seems likely that more 
than one critical time window during individual development may play a 
determinant role in programming offspring disease risks (Alfaradhi and Ozanne, 
2011). Animal studies are thus necessary to separate the wide range of 
confounding exposures and factors during the different developmental phases, 
which can influence offspring health outcome. Various animal models have 
already been used to address the transgenerational impact of DIO by fetal 
exposures throughout pregnancy and also the lactation period (Alfaradhi and 
Ozanne, 2011), which represents a critical time window for programming in 
rodents (Purcell et al., 2011; Sun et al., 2012). However, a greater paucity of 
animal studies have specifically investigated the transgenerational effects of 
maternal pre-gravid and gestational obesity (Shankar et al., 2008; Shankar et al., 
2010), although an impact on early embryo development has been suggested 
(Igosheva et al., 2010; Jungheim et al., 2010).  
So far, the outcomes of maternal obesity have mostly been determined 
in male offspring (Aiken and Ozanne, 2013) while only few studies have 
compared the effects on the two sexes (Khan et al., 2003; Han et al., 2005; Elahi 
et al., 2009; Nivoit et al., 2009; Bayol et al., 2010; Gallou-Kabani et al., 2010). 
These studies are highly relavant also given the reported sex-dependent 
association between parental BMI and children’s weight and body fat, an 
observation not being explained as yet (Whitaker et al., 2000; Danielzik et al., 
2002). Developmental components to sex-specific differences in human disease 
risk have also been reported for several common disorders (Ober et al., 2008), 
such as in diabetes (Mingrone et al., 2008).  
Chapter 2 describes a study aimed at assessing the metabolic, 
neuroendocrine as well as the behavioral profile of young adult offspring in a 
transgenic mouse model characterized by reduced oxidative stress, the p66Shc-/-
mouse. Data were analyzed in order to highlight if the reduced oxidative stress 
is a physiological condition that might exert a preventive role able to counteract, 
or at least limit, the effects resulting by prenatal exposure to a metabolic 
challenge represented by the maternal HFD. Since previous studies have already 
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demonstrated that the maternal environment experienced early during 
development affects fetal programming, setting the growth trajectory of the 
fetus through a different endocrine regulation in the two genders (Maccari et al., 
2003; Seckl and Holmes, 2007; Reynolds et al., 2013; Spencer, 2013), gender 
effects on physiological responses of the adult offspring were also assessed. 
More in general, all these effects were evaluated in the transgenic mouse model 
of reduced oxidative stress.  
The results obtained by the first study reveal, among other interesting 
results, a “protective” role exerted by the reduced oxidative stress toward the 
negative outcomes resulting by the maternal diet. These findings have lead to 
the study described in Chapter 3, in which are reported the effects resulting by 
the prenatal exposure to N-acetyl-cysteine(NAC), a drug characterized by 
remarkable antioxidant properties (De Flora et al., 1995a; De Flora et al., 
1995b). The time window of exposure to the NAC drug overlapped with 
maternal HFD exposure. This methodological choice was based upon the 
widely reported data related to the relevance of the prenatal programming on the 
physiological shaping of the adult individual (Barker, 1995), rendering such a 
period relevant for a preventive intervention. In this Chapter a main emphasis 
was placed on the ability of the NAC drug to counteract the effects of the HFD 
effect of the adult offspring.  
In Chapters 2 and 3 have been also described the effects of HFD 
exposure before and during pregnancy on the dams. Results indicate an HFD-
induced aberrant maternal behavior toward to the offspring, leading us to 
hypothesize that HFD feeding might represent a metabolic stressful challenge 
during pregnancy which might impair the establishment of maternal behavior 
with detrimental effects on the offspring.  
Thus, the studies described in Chapter 4 were mainly focused on 
investigating the effects of HFD feeding before and during pregnancy on the 
neuroendocrine and behavioral profile of dams in the perinatal period. The 
literature reviewed so far is mainly focused on the effects of maternal obesity or 
maternal high-fat feeding on the offspring and very few studies have paid 
attention to the effect of HFD on the mothers’ physiology during pregnancy and 
parturition. In Chapter 4 we proposed a model of HFD feeding before and 
during parturition in order to investigate its potential role as a metabolic 
stressor. The comprehension of the mechanisms underpinning the physiological 
adaptation of the mothers in response to HFD might lead to the identification of 
neuroendocrine and molecular markers predictive of a general physiological and 
behavioral alteration.  
All data are discussed in Chapter 5. 
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ABSTRACT 
Metabolic stressful challenges during susceptible time windows, such as fetal 
life, can have important implications for health throughout life. Deletion of the 
p66Shc gene in mice leads to reduced oxidative stress (OS), resulting in a healthy 
and lean phenotype characterized by increased metabolic rate, resistance to 
high-fat diet (HFD)-induced obesity and reduced emotionality at adulthood. 
Here we hypothesize that p66Shc−/− (KO) adult offspring might be protected from 
the detrimental effects induced by maternal HFD administered before and 
during pregnancy. To test such hypothesis, we fed p66Shc+/+ (WT) and KO 
females with HFD for 13 weeks starting on 5 weeks of age until delivery and 
tested adult male and female offspring for their metabolic, neuroendocrine, and 
emotional profile. Prenatal diet affected stress responses and metabolic features 
in a gender-dependent fashion. In particular, prenatal HFD increased plasma 
leptin levels and decreased anxiety-like behavior in females, while increasing 
body weight, particularly in KO subjects. KO mice were overall characterized 
by metabolic resiliency, showing a blunted change in glycemia levels in 
response to glucose or insulin challenges. However, in p66Shc−/− mice, prenatal 
HFD affected glucose tolerance response in an opposite manner in the two 
genders, overriding the resilience in males and exacerbating it in females. 
Finally, KO females were protected from the disrupting effect of prenatal HFD 
on neuroendocrine response. These findings indicate that prenatal HFD alters 
the emotional profile and metabolic functionality of the adult individual in a 
gender-dependent fashion and suggest that exposure to high-caloric food during 
fetal life is a stressful condition interfering with the developmental 
programming of the adult phenotype. Deletion of the p66Shc gene attenuates 
such effects, acting as a protective factor. 
Keywords: maternal obesity, p66Shc gene, oxidative stress, biomarkers, 
adipokines, gender, emotionality, animal models. 
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2.1. INTRODUCTION 
 
The environment experienced early during development is not only crucial for 
setting the growth trajectory of the fetus but represents also a key factor 
contributing to overall disease susceptibility in later life (Barker, 1995). In this 
context, developmental plasticity is a fundamental mechanism matching the 
growing organism to the environment it will face after birth (Barker, 2003). 
Early life stress can deeply influence developmental programming. In modern 
society maternal obesity - often associated with low socio-economic status - is 
an example of a physiological stressor experienced by women during pregnancy 
(Reynolds et al., 2013). Preclinical evidence, recently confirmed by clinical 
studies, suggest that such metabolic condition produces an adverse in utero 
environment for the offspring with long-term detrimental effects (Drake and 
Reynolds, 2010; Li et al., 2011). In particular, maternal obesity induces a 
chronic mild inflammatory state and high levels of oxidative stress (OS), 
resulting in frailty for psychiatric disorders and metabolic complications linked 
to an increased risk of insulin resistance (IR) and type 2 diabetes (T2D), in 
addition to cardiovascular disease and other metabolic disorders associated with 
obesity (Kahn and Flier, 2000; Wang et al., 2004; Fantuzzi, 2005; Taylor et al., 
2006; Eriksson et al., 2014). Likewise, high-fat feeding during pregnancy, 
independently from maternal obesity,causes per se placental dysfunction and 
metabolic impairment in the offspring (McCurdy et al., 2009; Frias et al., 2011). 
Preclinical studies have shown that extreme changes in maternal diet influence 
maternal stress responses and, likewise, affect offspring outcome, including 
adverse changes in behavior and memory (Weinstock, 2001), in cardiovascular 
responses to stress (Igosheva et al., 2007), in glucose tolerance (Lesage et al., 
2004), as well as sexual dimorphisms of brain regions associated with mood and 
hypothalamic-pituitary-adrenal (HPA) axis functions (Handa et al., 1994; 
Majdic and Tobet, 2011). Analyzing further these mechanisms could help 
identifying protective factors and lead to a better understanding of sex 
differences in the risk for metabolic and mood disorders reported in the adult 
population. These are important public health issues, given the abundance of 
dietary fats in western diets. 
The p66Shc gene is a mammalian gerontogene involved in metabolism 
and OS (Trinei et al., 2009) and plays a major role in the aging process. p66Shc 
is highly expressed within the adipose tissue and is involved in adipogenesis as 
it contributes to the intracellular insulin-mediated signaling pathway regulating 
fat accumulation (Berniakovich et al., 2008; Tomilov et al., 2011). In addition 
to resistance to OS, the lack of p66Shc gene leads to reduced trygliceride 
accumulation in the adipocytes, reduced fat mass, increased metabolic rate and 
resistance to diet-induced obesity in the mouse (Berniakovich et al., 2008; 
Tomilov et al., 2011). Furthermore, the p66Shc mutants show reduced 
emotionality, both in social and non-social contexts (Berry et al., 2007; Berry et 
al., 2008; Berry and Cirulli, 2013), associated to a mild hyperdrive of the HPA 
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axis (Berry et al., 2010). These physiological features of the p66Shc−/− mouse 
make it a powerful tool to investigate the mechanisms underlying the long-term 
consequences of maternal exposure to an obesogenic diet on metabolism and 
emotionality of the adult offspring.  
The current study was aimed at investigating the long-lasting effects of 
maternal high-fat feeding on the neuroendocrine, metabolic and behavioral 
phenotype of the adult offspring, paying particular attention to gender-specific 
outcomes. In addition, we aimed at identifying individual metabolic and/or 
neuroendocrine markers of vulnerability to metabolic and emotional disorders. 
Given the role played by the p66Shc gene in cellular metabolism, by 
mediating the insulin signaling, we hypothesized that the lack of this gene might 
exerts a protective role against the detrimental effects of maternal exposure to 
high-fat diet (HFD).To test such hypothesis, p66Shc+/+ (WT) and p66Shc−/− (KO) 
female mice were fed with HFD or control diet (CD) for 13 weeks: from 5 
weeks of age until right before delivery. Indeed, while several studies on the 
effects of maternal high- fat feeding have been performed by extending HFD 
exposure through pregnancy and/or lactation up until weaning, in this study we 
wanted to focus mainly on prenatal effects. The offspring was subsequently 
phenotyped for metabolic, neuroendocrine and behavioral responses. 
2.2. MATERIALSANDMETHODS 
2.2.1. Animals 
Experimental subjects were 5 weeks-old knock-out (KO - p66Shc−/−, n= 71) and 
wild-type (WT - p66Shc+/+, n= 77) female mice on a C57BL/6J background. 
Animals were housed 2/cage in transparent Plexiglas cages (37×21×19 cm) 
provided by Tecniplast, in an air conditioned room (temperature 21±1°C, 
relative humidity 60±10%) under a reversed 12/12h light/dark cycle with lights 
off from 07:00 a.m. to 07:00 p.m. Fresh tap-water and standard chow (standard 
diet - SD - energy 3.3 kcal/g, fat 17%, carbohydrate 60% and protein 23%, 
provided by Altromin-R, Rieper, Italy) were continuously available until 5 
weeks of age. Thereafter females were fed ad libitum either with HFD (energy 
5.56 kcal/g, fat 58%, carbohydrate 25.5% and protein 16.4%; n= 40 WT; 37 
KO) or control diet (CD - energy 4.07 kcal/g, fat 10.5%, carbohydrate 73.1% 
and protein 16.4%; n= 37 WT; 34 KO) for 10 weeks, i.e. until 15 weeks of age. 
Females of both genotypes were randomly assigned to HFD or CD groups 
avoiding difference in the average of body weight between groups. HFD 
(D12331) and CD (D12328) were provided by Research Diets, Inc., New 
Brunswick, NJ, USA. After 10 weeks on the diet, all females were mated with 
males of the same genotype. Body weight was monitored once a week to assess 
pregnancy. Pregnant females (n= 24 WT-CD; 19 KO-CD; 34 WT-HFD; 27 KO-
HFD) were kept with either HFD or CD throughout gestation until 3 days 
before the expected delivery date, i.e. at gestational day 16 (G16). Thereafter all 
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of them were switched to SD during lactation until pups weaning, occurring at 
post-natal day 30 (P30). Daily food consumption (24 h) and body weight gain 
of females maintained on HFD or CD were monitored once a week. The success 
of birth and the maternal behavior immediately after the birth of pups were also 
registered. In addition to nest dimension, pups’ body weight was also monitored 
during development at P3, P30 and at 3-months-old (P90). At weaning all pups 
were weaned onto SD and the onset of puberty markers were checked daily. At 
3 months of age, both males and females offspring were tested to assess the 
metabolic, neuroendocrine and emotional profiles resulting from prenatal 
exposure to a hypercaloric diet. At this age the Body Mass Index (BMI) of all 
subjects was also calculated as the ratio between body weight (g) and the square 
of the anal-nasal length (cm).  
A schematic design of the experimental plan is reported in Figure 1.  
Animal handling and experimental procedures were performed in 
accordance with the EC guidelines (EC Council Directive 86/609 1987) and 
with the Italian legislation on animal experimentation (Decreto L.vo 116/92). 
 
 
 
 
Figure 1. Schematic design of the experimental plan. 
 
 
2.2.2. Experimental procedure 
2.2.2.1. Onset of puberty 
The onset of puberty was assessed in all male and female pups, starting from the 
day of weaning (P30). Vaginal opening (VO) and balano-preputial separation 
(BPS) were chosen as puber- tal markers (Korenbrot et al., 1977; Rodriguez et 
al., 1997). Beginning on the day of weaning, the dates of VO for females and 
BPS for males were recorded. In female mice, VO was deter- mined by daily 
inspection and recorded as the day on which the vaginal orifice transitioned 
from tightly closed to patent (Nelson et al., 1990; Azooz et al., 2001; Zhou et 
al., 2007; Brill and Moenter, 2009). The opening of the vaginal cavity to the 
skin is an event occurring around the fifth week of life that can be induced in 
sexually immature mice by beta-estradiol injections (Rodriguez et al., 1997). 
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The separation of the prepuce from the gland penis (balanus) has been shown to 
be androgen depen- dent and to occur around the time of puberty (Korenbrot et 
al., 1977).   
2.2.2.2. Metabolic regulation 
• Glucose tolerance test (GTT). Intra-peritoneal GTT was performed after a 15 h
overnight fasting that took place from 06:30 p.m. until 09:30 a.m. Animals were 
intra-peritoneally (IP) loaded with 2 g/kg body weight D-glucose (10% D 
glucose solution; Sigma, St. Louis, MO, USA) (Satapathy et al., 2011). Blood 
was collected from the tail vein at 0 (baseline), 30, 60, 120 and 180 min 
(Ranieri et al., 2010) following IP injection and glycemia (blood glucose 
concentration) was measured using a commercial glucometer (StatStrip Xpress-
i, nova biomedical, A. Menarini diagnostic) (Titta et al., 2010). 
• Insulin sensitivity test (IST). The test was performed on animals starved for 5
h that took place from 09:30 a.m. until 02:30 p.m. Glycemia was measured 
using a commercial glucometer (StatStrip Xpress-i, nova biomedical, A. 
Menarini diagnostic) immediately before (0) and 15, 30, 60, 120 min after IP 
injection of a 0.4 U/kg body weight (Titta et al., 2010) solution of human 
recombinant insulin (Humulin, Eli-Lilly, 100 U/mL) (Ranieri et al., 2010). 
• Metabolic hormones assessment. Plasma levels of leptin and adiponectin were
assessed under starving condition. Blood samples were collected at 08:30 a.m., 
12 h after removal of the food, from the tail vein in potassium EDTA coated 
tubes (1.6 mg EDTA/ml blood; Sarstedt, Germany). After centrifugation, 
plasma samples were used for the determination of leptin levels, by a Mouse 
Leptin Elisa kit (Crystal Chem Inc., Downers Grove, IL) (Berniakovich et al., 
2008), in addition to adiponectin levels by an Elisa kit (B-Bridge International, 
Inc.) (Giorgio et al., 2012). The levels of adiponectin were also assessed in the 
epididymal/periovaric and mesenteric adipose tissues by immunoblot analysis. 
Epididymal/periovaric and mesenteric adipose tissue pads (100mg) were 
homogenized with Politron homogenizerin NaCl 150 mM, Tris 25 mM pH 6.8, 
EDTA 1 mM, supplemented with protease and phosphatase inhibitors, and 
centrifugated 1000 g for 10 min at 4°C, the fat pad fraction was discarded. A 
Bradford protein assay (Bio-Rad) was then conducted on the samples to 
determine the protein concentration for each sample. Proteins (20 mg) were 
separated by SDS-PAGE (10%) and transferred to nitrocellulose membranes. 
Membranes were blocked in 5% non-fat dry milk for 1 h and incubated with 
primary antibody for 1 h. Membranes were washed with TBS/0.1% Tween-20 
three times and incubated with secondary antibody for 1 h, then washed with 
TBS/0.1% Tween-20 three times and reac- tivity was detected by the enhanced 
chemiluminescence kit (Pierce). Blots were developed using a FluorChem™ R 
System. Mouse monoclonal adiponectin and actin antibodies were from Abcam, 
Inc. (Cambridge, MA). 
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2.2.2.3. Neuroendocrine activation  
The activation of the HPA axis was assessed in response to a psychophysical 
stressful challenge. All subjects underwent an acute restraint stress (30 min) and 
blood samples were col- lected by a tail nick at different time points, i.e. soon 
before (0 min) and following (30, 180 and 240 min) the exposure to stress, in 
order to measure plasma levels of corticosterone (CORT) (MP Biomedicals, 
LLC, Germany GmbH). Exposure to stress took place at 02:30 p.m., when the 
levels of free CORT were far from the circadian peak (Kitchener et al., 2004). 
 
2.2.2.4. Behavioral phenotype 
After 10 days of washout from the acute restraint stress, all sub- jects underwent 
behavioral testing to assess spontaneous behavior in the Open Field test, in 
addition to emotionality and general anxiety in the Elevated Plus Maze test 
(Pellow et al., 1985; File, 1993). These two tests were performed on different 
days. 
• Open field (OF). Each subject was individually placed in the center of a cubic 
arena (open field box 40×40×40 cm) made of Plexiglas and allowed to freely 
explore for a single session lasting 15 min. The OF box was ideally divided into 
25 squares and ideally partitioned into a central portion (24×24 cm) and a 
peripheral one, identified as the remaining part of the arena. When data were 
analyzed, the session was subdivided in three time blocks (tb), lasting 5 min, 
and the time spent in each portion of the arena was measured. Furthermore, the 
duration of locomotion (crossings of squares limits with all paws) was scored as 
index of exploratory behavior. 
• Elevated plus maze (EPM). The EPM is made of two open arms(30×5×0 cm) 
and two closed arms (30×5×15 cm) that extend from a common central platform 
(5×5 cm). The apparatus, made of Plexiglas (gray floor, clear walls), is elevated 
to a height of 60 cm above the floor. Mice were individually placed on the 
central platform facing an open arm and allowed to freely explore the maze for 
5 min. Behavioral parameters observed were: % open entries [(open/total)×100] 
and time spent in the open and closed arms of the maze (File, 2001). 
Furthermore, the behavioral parameters taken into account were the total 
amount of time spent in immobility and self-grooming, a self-directed behavior 
providing a reliable marker of anxiety (Kalueff and Tuohimaa, 2005).  
In all behavioral tests, after each trial/session, the apparatus was cleaned 
with 50% ethanol to reduce olfactory cues.  
At 9 weeks of age mice began the experimental procedure. All subjects 
underwent the GTT as first metabolic test and after 3 days, in which mice were 
left undisturbed, all of them were tested for the IST. This time interval was 
necessary to recover from the fasting and the handling procedures. Five days 
after the IST the neuroendocrine activation was assessed. After 10 days from 
the end of the stress procedure subjects underwent the behavioral tests. 
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2.2.2.5. Tissue collection 
At 3 months of age all subjects were sacrificed and the epididymal/periovaric 
and mesenteric adipose tissue depots dissected out and immediately stored at -
80°C for further analysis. 
 
2.2.3. Statistical analysis 
Data were analyzed using parametric analysis of variance (ANOVA) with diet 
(HFD vs. CD), genotype (WT vs. KO) and gender (females vs. males) as 
between-subjects factors and minutes, zones (EPM: “center” vs. “closed arms” 
vs. “open arms”; OF: “center” vs. “periphery”) and time blocks (0-5 vs. 5-10 vs. 
10-15 min) as within-subject repeated measures, when appropriate (GTT, IST, 
CORT measurement, EPM and OF tests).  
Post-hoc comparisons have been performed using the Tukey’s test. A 
linear regression model was used to assess the effect of body weight on the 
onset of puberty in the offspring. Fisher’s exact probability test was used to 
compare genotypes and diets for reproductive success of the colony (i.e. number 
of pregnant females died during the perinatal period and number of litters in 
which cannibalistic episodes took place: two-by-two contingency table). 
Statistics were performed with Statview II (Abacus Concepts, CA, USA). 
 
2.3. RESULTS 
 
2.3.1. Dams’ body weight and food consumption 
Regardless of genotype, dams fed HFD registered a lower daily food 
consumption than controls (main effect of diet: F(1,59)= 14.023, p= 0.0004, 
Figure 2A). Nevertheless, regardless of genotype, HFD determined an increase 
in body weight during the 10 weeks on diet (main effect of diet: F(1,144)= 22.348, 
p< 0.0001, Figure 2B). 
 
 
 
 
Figure 2. Effect of high-fat feeding on dams. Food consumption (A) and body weight (B) of 
dams feed HFD. Data are shown as + s.e.m. Post-hoc comparisons, ∗∗p< 0.01(hfd vs. cd). 
Experimental subjects, cd-wt/ko, n= 37/34; hfd-wt/ko, n= 40/37. 
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2.3.2. Success of birth, cannibalistic behavior and litter size 
Feeding HFD results in an increased dams’ mortality associated to pregnancy 
(Fisher’s exact probability test: p= 0.0266, Table 1A) and increased frequency 
of cannibalistic episodes (Fisher’s exact probability test: p= 0.0308, Table 1B) 
only in WT subjects; interestingly such phenomena were strongly reduced in the 
p66Shc−/− dams. Regardless of genotype, the HFD affected the littersize reducing 
the number of pups (main effect of maternal diet: F(1,64)= 9.134, p= 0.0036, 
Table 1C). 
 
 
 
 
Reduced mortality associated to pregnancy (A) and reduced frequency of cannibalistic episodes 
(B) in KO females fed HFD. Reduced size of litters on HFD (C). In the section (A,B), the table 
reports the number of dams on diet; in the section (C) the table reports the average number of 
pups per litter ± s.e.m. 
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2.3.3. Offspring body weight and BMI 
Overall, exposure to maternal HFD resulted in a decreased body weight at P3 
(main effect of maternal diet: F(1,58)= 3.835, p= 0.05, data not shown), in the 
p66Shc−/− offspring (interaction between maternal diet and genotype: F(1,58)= 
12.120, p= 0.0010, Figure 3A). This effect was reverted during growth (P30) 
(main effect of maternal diet: F(1,85)= 15.225, p= 0.0002, data not shown), 
particularly in males (interaction between maternal diet and gender: F(1,85)= 
4.099, p= 0.0461, data not shown). In addition, at this age, a specific HFD-
induced increase in body weight was found in the p66Shc−/− offspring (interaction 
between maternal diet and genotype: F(1,85)= 6.252, p= 0.0143, Figure 3B). 
Thus, prenatal HFD was able to override the p66Shc−/− lean phenotype (Figure 
3B). Overall, the fatting effect of the HFD was maintained until adulthood 
(P90), when HFD offspring, regardless of genotype and gender, showed a 
higher body weight than CD subjects (main effect of maternal diet: F(1,85)= 
4.930, p= 0.0291, data not shown). The interaction between maternal diet and 
gender, observed at P30, was overturned during growth (P90), when higher 
body weight was observed only in HFD females (interaction between maternal 
diet and gender: F(1,85)= 6.018, p= 0.0162, data not shown). As for P30, while no 
difference was observed in WT subjects, KO-HFD offspring maintained a 
higher body weight compared to KO-CD until 3 months of age (P90) 
(interaction between maternal diet and genotype: F(1,85)= 8.236, p= 0.0052, 
Figure 3C), particularly in males (interaction among maternal diet, genotype 
and gender: F(1,85)= 8.447, p= 0.0047, data not shown).  
Figure 3. Body weight of the offspring after birth, P3(A), at weaning, P30 (B), and at 3 
months of age, P90 (C). Data are shown as + s.e.m. Post-hoc comparisons, ∗p< 0.05 (P3 and 
P90: hfd-ko vs. cd-ko); $ p< 0.01 (P30: cd-ko vs. cd-wt); ∗∗ p< 0.01 (P30: hfd-ko vs. cd-ko). 
Experimental subjects, P3: cd-wt, n= 16; cd-ko, n = 15; hfd-wt, n= 15;hfd-ko, n= 20; P30 and 
P90: cd-wt-f/m n= 15/10; cd-ko-f/m n= 9/14; hfd-wt-f/m n= 11/9; hfd-ko-f/m n= 11/14. 
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Regardless of genotype, maternal HFD reduced the difference in BMI usually 
observed between genders, increasing the BMI of female mice and rendering 
them more similar to males (interaction between maternal diet and gender: 
F(1,60)= 3.820; p= 0.05, Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Body mass index. Data are shown +s.e.m. Post-hoc comparisons, ∗p< 0.05 (hfd-f vs. 
cd-f). Experimental subjects, cd-wt-f/m n = 8/9; cd-ko-f/m n = 8/9; hfd-wt-f/m n = 8/9; hfd-ko-
f/m n = 7/10. 
 
 
2.3.4. Onset of puberty 
Offspring of HFD- and CD-fed dams did not differ as for their onset of puberty 
(main effect of maternal diet: F(1,130)= 0.750; p= 0.3881; interaction among 
maternal diet, genotype and gender: F(1,130)= 0.790; p= 0.3757, data not shown). 
However, and most intriguingly, while in CD subjects this parameter was 
associated to changes in body weight (F(1,14)(1,9)(1,9)(1,10)= 6.213; 12.808; 14.582; 
6.526, p= 0.027; 0.0072; 0.0051; 0.0339, R2= 0.323; 0.616; 0.646; 0.449, 
respectively for females WT-CD and KO-CD; males WT-CD and KO-CD, 
Figure 5B), this did not occur in HFD offspring (F(1,19)(1,10)(1,19)(1,13)= 0.041; 
1.496; 0.006; 0.923, p= 0.8945; 0.8444; 0.9419; 0.3557, R2= 0.005; 0.143; 
0.001; 0.071, respectively for females WT-HFD and KO-HFD; males WT-HFD 
and KO-HFD, Figure 5A), suggesting that the exposure to HFD during fetal 
programming might have affected the surge of gonadal hormones, resulting in a 
disorganized pubertal development. Regardless of diet, lack of p66Shc delayed 
the time of puberty (main effect of genotype: F(1,130)= 6.987, p= 0.0092, data not 
shown) probably by the lower body weight characterizing the transgenic model 
and that is known to be relevant in the onset of puberty. This latter point could 
also justify the delayed onset of puberty observed in female mice (main effect 
of gender: F(1,130)= 20.935, p< 0.0001, data not shown). 
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Figure 5. Onset of puberty. Correlation between offspring’s body weight and timing of puberty 
in male and female HFD (A) and CD (B) offspring. Experimental subjects: cd-wt-f/m, n= 15/10; 
cd-ko-f/m, n= 10/11 hfd-wt-f/m, n= 10; hfd-ko-f/m, n= 11/14. 
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2.3.5. Metabolic regulation 
• Glucose tolerance test (GTT). In both genders and regardless of prenatal diet, 
p66Shc−/− mice were resistant to an increase in blood glycemia upon glucose 
injection (main effect of genotype: F(1,77)(1,66)= 11, 817; 9.018, p= 0.0009; 
0.0038, respectively for male and female subjects, inserts Figures 6A, B). In 
addition, the HFD affected the metabolic response to GTT in an opposite 
manner in the two genders, overriding the p66Shc−/− resilience, rendering the 
glycemic response of p66Shc−/− male mice comparable to that observed in control 
subjects (interaction among maternal diet, genotype and time course: F(4,308)= 
1.078; p= 0.3676, Figure 6A) and, on the contrary, exacerbating the metabolic 
resilience of p66Shc−/− females (interaction among maternal diet, genotype and 
time course: F(4,264)= 4.240; p= 0.0024, Figure 6B). 
• Insulin sensitivity test (IST). Regardless of genotype, prenatal exposure to 
HFD led to insulin insensitivity later in life (3-months-old) as demonstrated by 
the higher glycemia observed in young adults (main effect of maternal diet: 
F(1,77)(1,66)= 3.702; 15.504, p= 0.05; 0.0002, respectively for male and female 
subjects, inserts Figures 6C, D). As already observed in the GTT, overall, KO 
mice were characterized by a resilient metabolic profile showing higher blood 
glucose levels in response to a stimulus of insulin (main effect of genotype: 
F(1,77)(1,66)= 21.473; 6.635, p< 0.0001; 0.0122, respectively for male and female 
subjects, inserts Figures 6C, D). 
• Metabolic hormones. Overall, exposure to maternal HFD did not affect plasma 
levels of adiponectin in adul toffspring (main effect of maternal diet: F(1,62)= 
2.392; p= 0.1271, data not shown). In addition, females were characterized by 
higher peripheral levels of adiponectin than males (main effect of gender: 
F(1,62)= 5.497; p= 0.0223, data not shown). While no differences were observed 
among male mice regarding both diet and genotype, a greater metabolic 
variability was found in females. KO female mice prenatally exposed to CD 
were characterized by higher plasma levels of adiponectin than the WT females 
and KO males exposed to the same maternal diet (interaction among maternal 
diet, genotype and gender: F(1,61)= 12.691; p= 0.0007, Figure 7A). Females 
were characterized by higher levels of adiponectin also in the adipose tissue 
(main effect of gender: F(1,32)= 6.814; p= 0.0136, data not shown), in particular 
in the mesenteric fat tissue (interaction between gender and adipose tissue: 
F(1,32)= 10.396; p= 0.0029, data not shown). In addition, we found a strong 
tendency in increased levels of adiponectin in the mesenteric fat tissue in KO 
females (interaction among genotype, gender and adipose tissue: F(1,32)= 3.778; 
p= 0.0608, data not shown). 
Regardless of genotype, prenatal exposure to HFD led to a sig nificantly 
higher plasma levels of leptin in females, compared to males (interaction 
between maternal diet and gender: F(1,50)= 5.503; p= 0.0230, Figure 7B). 
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Figure 6. Metabolic regulation. Glucose tolerance assessment in WT and KO male (A) and 
female (B) offspring fed CD or HFD. Insulin sensitivity test in WT and KO male (C) and female 
(D) offspring fed CD or HFD. Data are shown as ± s.e.m. Post-hoc comparisons, $ p< 0.05 (cd vs. 
hfd); ∗ p< 0.05 (ko vs. wt); ∗∗ p< 0.01. Experimental subjects: cd-wt-f/m, n= 17/22; cd-ko-f/m, n= 
18/19; hfd-wt-f/m, n= 18/22; hfd-ko-f/m, n= 17/18. 
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Figure 7. Metabolic hormones. Plasma levels of adiponectin (A) and leptin (B) in male and 
female mice prenatally exposed to CD or HFD. Data are shown as + s.e.m. Post-hoc comparisons, 
∗ p< 0.05 (adiponectin: cd-ko-f vs. cd-wt-f and cd-ko-m; leptin: hfd-f vs. hfd-m). Experimental 
subjects, adiponectin assessment: cd-wt-f/m, n= 9; cd-ko-f/m, n= 8/9; hfd-wt-f/m, n= 8/9; hfd-ko-
f/m, n= 8/10; leptin assessment: cd-wt-f/m, n= 7/9; cd-ko-f/m, n= 8/7; hfd-wt-f/m, n= 5/7; hfd-ko-
f/m, n= 7/8. 
 
 
2.3.6. Neuroendocrine activation 
In female mice maternal HFD exacerbated the HPA axis response to an acute 
psychophysical stress, increasing the plasma levels of corticosterone (main 
effect of maternal diet: F(1,32)= 6.058, p= 0.0194, data not shown). The 
interaction between maternal diet and genotype was statistically significant 
(F(1,32)= 7.395, p= 0.0105, Figure 8). In particular, while the WT females 
showed a marked increase in corticosterone levels in response to stress when 
exposed to maternal HFD, KO females were protected from the negative effects 
of the maternal HFD, showing a neuroendocrine response similar to KO-CD 
(Figure 8A). Moreover, KO females prenatally exposed to HFD showed a 
prompt feedback of the HPA axis activation displaying a neuroendocrine profile 
more similar to that of WT-CD subjects (interaction between maternal diet, 
genotype and time course: F(3,96)= 2.583; p= 0.05, Figure 8B). No differences in 
the neuroendocrine activation were observed in male mice in response to the 
acute restraint stress (interaction among maternal diet, genotype and time 
course: F(3,87)= 0.735; p= 0.5342, data not shown). 
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Figure 8. Neuroendocrine activation. Neuroendocrine activation in female mice in response to 
an acute restraint stress (A) and feedback response of the HPA axis activation (B). Data are 
shown as + s.e.m. Post-hoc comparisons, ∗ p< 0.05 (hfd-wt vs. hfd-ko and wt-cd, at 180 min; hfd-
ko vs. hfd-wt, at 240 min); ∗∗ p< 0.01 (hfd-wt vs.cd-wt and hfd-ko). Experimental subjects: cd-
wt, n= 10; cd-ko, n= 8; hfd-wt/ko, n= 9. 
2.3.7. Behavioral phenotype 
• Open field(OF). Overall, regardless of prenatal diet and genotype, all subjects
- both males and females – spent significantly less time in the center of the 
arena, that represents the anxiogenic portion of the apparatus (main effect of 
zones: F(1,56)= 5751.755; p< 0.0001, data not shown). Regardless of both 
genotype and gender, prenatal exposure to HFD gradually reduced locomotion 
(duration of crossings) during the test (interaction between maternal diet and tb: 
F(2,178)= 3.910; p= 0.0218, Figure 9A). While no difference emerged between 
HFD subjects, interestingly, from the assessment of spontaneous behavior 
emerged that WT subjects performed an uncommon behavior of jumping toward 
the wall of the apparatus and more frequently than KO (Fisher’s exact 
probability test: p= 0.0361, data not shown). This behavior indicates an attempt 
to leave the apparatus and greater risk-taking and aggressive exploration 
representing an escaping strategy from a novel context. This data suggests that 
prenatal exposure to HFD reduced activity both in WT and KO mice and that 
overall KO subjects were less anxious than WT. 
• Elevated plusmaze(EPM). Regardless of prenatal diet, genotype and gender,
overall, all subjects spent more time in the closed arms of the maze compared to 
both center and open arms (main effect of zones: F(2,176)= 29.312; p< 0.0001, 
data not shown). In addition, prenatal diet, genotype and gender did not affect 
the percent frequency of entries in the open arms (main effects respectively of 
prenatal diet, genotype and gender: F(1,58)= 0.038; 0.497; 1.150; p= 0.8463; 
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0.4838; 0.2879, data not shown). Regardless of genotype, exposure to maternal 
HFD in utero increased the duration of immobility, a reliable index of anxiety-
like behavior, in male mice and seemed to reduce that in females (interaction 
between maternal diet and gender: F(1,88)= 3.735; p= 0.05, Figure 9C) 
suggesting a feminization of males exposed to maternal HFD. A similar gender 
inversion of the behavioral phenotype in response to prenatal exposure to HFD 
was also related to the time spent in displacement behavior (grooming) 
(interaction between maternal diet and gender: F(1,88)= 7.245; p= 0.0085, Figure 
9B). The inversion in the anxious profile in the subjects prenatally exposed to 
an obesogenic diet suggests that HFD affected the behavioral profile differently 
in the two genders, increasing anxiety in male mice and rendering females more 
uninhibited. 
 
 
 
 
Figure 9. Behavioral phenotype. Duration of locomotor activity in the Open Field test (A). 
Feminization of males’ emotional profile prenatally exposed to HFD measured by the duration of 
grooming (B) and immobility (C) in the Elevated Plus Maze test. Data are shown as + s.e.m. Post-
hoc comparisons, ∗ p< 0.05 (OF: hfd 0-5 vs. 5-10); ∗∗ p< 0.01 (hfd vs. cd at 5-10 and 10-15 min); 
∗ p< 0.05 (EPM: hfd-f vs. cd-f; hfd-m vs. cd-m). Experimental subjects, n= 12. 
 
 
2.4. DISCUSSION 
 
Overall, results of this study reveal that HFD, administered before and during 
pregnancy, has detrimental effects on both the dam and the offspring. 
Reproductive success in both WT and KO females is compromised by exposure 
to HFD, which leads to increased maternal mortality rate during pregnancy and 
increased frequency of cannibalistic episodes immediately after delivery. The 
most relevant findings are the long-lasting and gender-dependent effects of 
maternal HFD feeding on metabolic and neuroendocrine profile of the adult 
offspring. Maternal HFD produced more marked consequences in the adult 
female offspring, such as increased BMI and higher leptin levels compared to 
the CD group. Even greater effects were found in interaction with p66Shc 
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deletion, KO female offspring showing enhanced glucose tolerance and insulin 
resistance, in addition to being protected from HPA axis hyperactivity induced 
by HFD.  
Our data indicate that high-fat feeding for 13 weeks till delivery results 
in maternal body weight gain accompanied by a reduced daily HFD 
consumption, possibly due to the high energetic and caloric intake associated 
with HFD. In addition, we found an increased mortality rate of pups born from 
HFD-fed dams, as a result of cannibalistic events and a strong association 
between HFD and maternal mortality in the days immediately before the 
expected delivery date, or during parturition. Furthermore, we found that 
maternal HFD results in a decreased number of pups delivered that may be due 
to composition of dietary fatty acids which reportedly affect fertility and induce 
a higher resorption number (Buckley et al., 2005). It is worth noting that similar 
findings have been previously reported by Flint and co-workers, in mice, and 
others in a different species, the rat, further corroborating the critical role played 
by maternal diet in such time window (Siemelink et al., 2002; Buckley et al., 
2005; Flint et al., 2005). In this context, the lack of the p66Shc gene plays a 
protective role, at least for selected parameters such as dam mortality and 
cannibalistic behavior.  
We have observed that pups of HFD-fed dams showed a significantly 
lower body weight at birth (P3) but an increased weight during adolescence and 
at adulthood (P30 and P90). Such effect was significantly marked only in the 
p66Shc−/− mice. These data are consistent with previous studies reporting that 
poor fetal growth programs pups to quickly catch-up in adult life (Ozanne and 
Hales, 2004; Bieswal et al., 2006). Also Flint, et al., 2005 found a markedly 
decreased weight gain in mice pups of HFD-fed dams during the first day of 
lactation, as a result of an impairment of the mammary gland function, and 
consequent reduced milk production, induced by the diet. However, in line with 
our results showing an increased body weight in HFD offspring during 
adolescence and adulthood, such impairment was recovered in the following 
days (Flint et al., 2005).  
Despite HFD induced differences in body weight, no change has been 
registered in the BMI. Such discrepancy may be due to the fact that, 
notwithstanding BMI is considered an adequate index of adiposity, it is poor at 
discriminating the ratio of fat to lean tissue (Wells et al., 2006), thus resulting 
not strictly related to body weight. Indeed, in the maternal-HFD exposed 
offspring, adult females, compared to males, had a lower body weight while 
showing an increased BMI.  
In the present study, we did not find an effect of HFD on the onset of 
puberty either in males or in females. These results are apparently not in line 
with some previous studies showing that HFD exposure during pregnancy 
and/or the early postnatal period advances puberty onset in female rats 
(Boukouvalas et al., 2008; Chang et al., 2008; Sloboda et al., 2009; Akamine et 
al., 2010; Boukouvalas et al., 2010; Li et al., 2012). Such discrepancy may be 
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due to the fact that percent of fat content has been suggested to be critical for 
the quality of the effects produced by the diet (Chang et al., 2008; Moral et al., 
2011; Lie et al., 2013). Indeed, advancement of puberty onset has been found in 
studies using a diet containing not more than 45% of fat, while the HFD used in 
the current study, with a 58% fat content, did not advance puberty onset as in 
other studies using similar diets (Lie et al., 2013). 
In addition to diet, body weight affects puberty according to an inverted 
relation, with increased body weight associated with earlier pubertal onset 
(Rosenfield et al., 2009). Accordingly, we found such inverted relation in 
experimental groups exposed to CD. However, in the HFD-KO group, the 
increased body weight did not go with a change in the mean age of puberty. 
This may be due to the disrupting effect of HFD on such relationship described 
here and in previous studies. In particular, perturbations of the timing of female 
puberty has been found in rats exposed to metabolic stress in utero, induced 
through administration of hypercaloric diet to the mother (Ibanez and de 
Zegher, 2006b, 2006a; Ibanez et al., 2006). This effect might be mediated by an 
alteration of gonadal hormones secretion (Mah and Wittert, 2010; Teerds et al., 
2011; Pinilla et al., 2012) resulting in a disorganized pubertal development of 
the offspring. Such effect warrants to be further investigated.  
Here we found that p66Shc gene regulates response to metabolic stimuli. 
In particular, KO mice show a greater resistance toward glucose challenge 
compared to WT. Such effect was affected by the diet in a gender-dependent 
fashion. Indeed, in KO females prenatally exposed to HFD, we observed a 
higher glucose tolerance demonstrating a better ability to metabolize the excess 
of blood glucose while, in KO males, we found an opposite profile as HFD 
determined severe glucose intolerance in comparison with their own controls 
(CD-KO). It is not possible to exclude that measuring glycemia sooner after the 
metabolic challenge (e.g., after 15 min) might provide additional information.  
In the light of these points, it is reasonable to suggest that HFD 
overrides the effects of p66Shc−/− on metabolism in males, reducing the glucose 
resilience, and exacerbating it in females. Accordingly, we found that the lack 
of the p66Shc gene leads to greater resistance in the IST test. Resilience to an 
insulin challenge was affected not only by the genotype, but also by the 
maternal diet, since HFD individuals showed greater insulinin sensitivity. In 
particular, such insulin resistance has been suggested by (Turdi et al., 2013) to 
result from a severely dampened insulin-signaling-cascade. The metabolic 
alterations described in KO mice may be due to the reported involvement of 
p66Shc gene in insulin signaling (Berniakovich et al., 2008), which leads to 
hypothesize that its deletion results in insulin desensitization with the 
consequent impairment in the metabolism of glucose.  
Leptin is involved in the long-term regulation of body weight and 
energy balance by acting as a hunger suppressant signal to the brain and has 
been found to be increased in obese subjects (Hamed et al., 2011). In the present 
study, maternal HFD results in a difference in leptin plasma levels between 
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genders in the adult offspring. Prior and colleagues found that offspring from 
HFD-fed dams exhibits an altered hypothalamic sensitivity to leptin, suggesting 
that metabolic alteration occurring in a susceptible time window for the 
developing organism impairs central mechanisms regulating leptin secretion at 
adulthood (Prior et al., 2013). Previous studies have already demonstrated that 
the maternal environment affects fetal programming, driving the development 
of central nervous system circuitries through a different endocrine regulation in 
the two genders (Maccari et al., 2003; Seckl and Holmes, 2007; Reynolds et al., 
2013; Spencer, 2013).  
Increased adiponectin levels were found both in plasma and in adipose 
tissues in KO females. Adiponectin is produced by adipocytes and its 
expression is inversely related to adipose tissue mass (Yamauchi et al., 2001; 
Antoniades et al., 2009; Ntaios et al., 2013), a result in line with the reduction 
of fat tissue found in KO females. In addition, as adiponectin enhances 
hippocampal neurogenesis (Zhang et al., 2011), the increased levels of this 
adipokine in KO females fit with our previous data showing increased 
neurogenesis in aged KO females (Berry et al., 2012).  
One of the main findings of this study is the programming effect of 
HFD on the neuroendocrine fetal development, which leads to greater 
susceptibility to stressful challenges later in life. In particular, we found that 
HFD significantly increases the response to an acute restraint stress in adult WT 
females. This effect may be due to an impairment of the negative feedback of 
the HPA axis, as suggested by the long lasting increase in corticosterone levels 
induced by the stressor. Interestingly, despite their exposure to maternal HFD, 
KO females were protected from such effect, showing an efficient HPA axis 
feedback, undistinguishable from CD. It is worth noting that the alterations of 
the neuroendocrine profile induced by maternal HFD overlap with those 
induced by prenatal stress. For instance, Louvart and colleagues reported that 
female offspring of rat dams exposed to a chronic restraint stress during the last 
trimester of pregnancy display at adulthood a higher response to restraint stress 
(Louvart et al., 2009). The overlapping consequences of maternal HFD and 
exposure to stressful conditions during the prenatal period leads us to 
hypothesize that maternal HFD mimics psychophysical stress, as both interfere 
with the fetal programming of neuroendocrine development, altering the HPA 
axis activity during the entire lifespan (Maccari et al., 2003; Seckl and Holmes, 
2007; Reynolds et al., 2013; Spencer, 2013).  
Previous studies have reported increased anxiety-like behavior in adult 
subjects of both genders exposed to HFD during fetal development (Peleg-
Raibstein et al., 2012), although in some cases a gender dependent effect is 
reported (Bilbo and Tsang, 2010). In line with the latter finding, we show 
different effects in males and females. In particular, we observed increased 
grooming levels in the EPM, considered an endpoint of anxiety-like behavior, in 
CD females compared to CD males. Such difference in basal levels of anxiety 
response between genders is widely described in the literature (Kessler et al., 
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1994; Weissman et al., 1994; Kessler et al., 1995; Weissman et al., 1996; Gater 
et al., 1998). However, such profile was inverted by the exposure to maternal 
HFD, suggesting a feminization of the emotional profile of male mice. This is 
especially interesting in light of the results from prenatally stressed subjects, 
which are characterized by the same feminization effect (Weinstock, 2001). 
Such finding corroborates the idea that prenatal metabolic alterations acts as a 
psychophysical stressful stimulus with potential implications for brain function, 
both at adulthood and during the aging process, confirming the data about the 
neuroendocrine profile observed in HFD-WT females (Maccari et al., 1995; 
Maccari et al., 2003; Spencer, 2013). 
Overall, results from this study indicate that maternal HFD might 
represent a detrimental metabolic stimulus for the dam and, in particular, for the 
offspring. Since our model of HFD feeding did not lead to maternal obesity, the 
observed effects on the offspring are purely due to alterations of maternal 
metabolism. In particular, in our study, maternal HFD seems to be a condition 
sufficient to induce “metabolic misprogramming” causing offspring metabolic 
and neuroendocrine alterations. Moreover, the gender-dependent effects here 
described might suggest a potential modulating role played by sex hormones on 
the long-term consequences of maternal HFD on the offspring. To explore such 
hypothesis further studies are warranted.  
Finally, the overall resilience of the KO in response to metabolic 
challenges confirms the notion that p66Shc is an important molecular target for 
future studies investigating pathological states induced by stressful or metabolic 
factors during early life. 
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ABSTRACT 
Previous data have shown that maternal high-fat diet (HFD) throughout 
gestation has long-term consequences on the offspring’s metabolic phenotype. 
More interestingly, these data showed a reduced incidence of the detrimental 
long-lasting effect of maternal HFD during fetal development in an animal 
model of reduced oxidative stress (OS), the p66Shc-/- mouse, thus suggesting a 
protective role played by this condition in a such susceptible period of the 
individual life. We hypothesized that a fetal environment characterized by 
decreased OS might represent a healthy condition able to thwart the effect of 
maternal HFD on the fetal programming, possibly reducing HFD-induced long-
term effects on the offspring both on metabolic and emotional phenotype. To 
test such hypothesis, female C57BL/6J mice were fed a HFD for 13 weeks, 
starting on 5 weeks of age until delivery, and were exposed to N-acetyl-cysteine 
(NAC) drug for 8 weeks (from 10 weeks of age until right before delivery). 
Adult offspring of both genders were tested at three months of age for their 
metabolic, neuroendocrine and emotional profile. Overall, results of the study 
show that prenatal exposure to NAC counteracted some of the negative effects 
played by HFD on the adult offspring. Despite that, NAC during pregnancy 
failed to restore reproductive success in HFD female mice. NAC drug 
reproduced the metabolic effects of the p66Shc gene deletion, conferring glucose 
tolerance and insulin resistance to young adult male offspring. In addition, 
maternal HFD and NAC differently affected the metabolic phenotype of the 
offspring of both genders, suggesting a long-lasting and gender-dependent 
effect. Moreover, prenatal NAC overturned the effect of maternal HFD on the 
emotional and behavioral phenotype of the offspring. Overall, NAC mimicked 
the effects associated to the lack of the p66Shc gene, at least as concerning the 
metabolic response, confirming the strict relationship between oxidative stress 
and metabolism. 
Keywords: antioxidant, N-acetyl-cysteine, high-fat diet, pregnancy, 
metabolism, animal models. 
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3.1. INTRODUCTION 
 
In modern society the consumption of high fat diet (HFD) as well as a sedentary 
lifestyle has been associated with metabolic derangements and impairment of 
brain function (Schrauwen and Westerterp, 2000; Unger and Orci, 2001; 
McGarry, 2002; Molteni et al., 2002; Molteni et al., 2004). While it is generally 
accepted that HFD-induced obesity per se is associated with adverse health 
outcomes, studies have also shown that maternal obesity is specifically 
associated with a variety of pregnancy complications, fetal and neonatal death, 
maternal hypertension and gestational diabetes (Lu et al., 2001; Bhattacharya 
and Sood, 2007; Thompson, 2008). It is possible that maternal obesity might 
precipitate adverse outcomes that persist through adulthood in offspring. 
Indeed, evidence suggests that epigenetic events initiated during the prenatal 
period can result in persistent adaptations in structure, physiology and 
metabolism predisposing offspring towards disease and impaired physiology 
(Barker, 1995; Lucas, 1998). Furthermore, in addition to negatively impacting 
metabolic regulation, resulting in excess energy intake, increased adiposity and 
overall impaired several metabolic processes (Woods et al., 2004; Zhang et al., 
2009), HFD is also associated with a low grade inflammation and an increased 
production of inflammatory cytokines (Chandalia and Abate, 2007).  
Several studies have shown that administration of high fat or high 
calorie diets to rodents increases the generation of reactive oxygen species 
(ROS) (Zhang et al., 2005) and protein oxidation (Souza et al., 2007), thus 
resulting in increased oxidative damage in the brain (Cecarini et al., 2007; 
Bruce-Keller et al., 2009; Zhang et al., 2009) and, more in general, in oxidative 
cell injury (Gutteridge and Halliwell, 2000). This experimental evidence is 
consistent with the possibility that increased oxidative stress (OS), in turn, 
mediates the effects of HFD consumption both on brain pathogenesis and 
cognitive disturbances and exacerbates HFD-related metabolic impairment. 
In a previous work (Bellisario et al., 2014) it was found that the 
detrimental effect of prenatal exposure to a maternal HFD was counteracted by 
the lack of the p66Shc gene that results, among several features, in reduced OS 
and resistance to diet-induced obesity. These findings suggested that the 
reduced OS might represent the key mechanism resulting in increased resistance 
to impaired physiological adaptation driven by maternal HFD in offspring 
during adult life. In light of that, this study was aimed at developing a 
pharmacological model of reduced OS able to cope with metabolic challenges 
occurring during early life by means of prenatal administration of N-acetyl-
cysteine (NAC). This drug is an analogue and precursor of reduced glutathione 
and its clinical efficacy and safety have been widely established in the lasts 
decades as a mucolytic drug, in the therapy of respiratory diseases and, more 
recently, as a remedy towards several acute intoxications (Crystal, 1991). More 
importantly, NAC works through a variety of coordinated mechanisms, the 
most important of which depend on its remarkable antioxidant properties, which 
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warrant possible applications in the prevention of cancer and other pathological 
conditions associated with damage by free radicals (De Flora et al., 1995a; De 
Flora et al., 1995b). Given this evidence, we hypothesize that the administration 
of the antioxidant NAC during prenatal life might counteract with a greater 
efficacy the negative effects exerted by the maternal HFD on fetus 
development. To test such hypothesis female mice were fed a HFD or control 
diet (CD) for 13 weeks (from 5 weeks of age until right before delivery) and 
were exposed to NAC drug for 8 weeks (from 10 weeks of age until right before 
delivery). The offspring was subsequently phenotyped for metabolic and 
behavioral responses at adulthood. 
3.2. MATERIALS AND METHODS 
3.2.1. Animals 
Experimental subjects were the male and female adult offspring (3 months of 
age) of C57BL/6J female mice fed experimental diets.  
All mice were housed 2/cage in transparent Plexiglas cages provided by 
Tecniplast, in an air-conditioned room (temperature 21±1°C, relative humidity 
60±10%), under a reversed 12/12 h light/dark cycle with lights off from 07:00 
a.m. to 07:00 p.m. Fresh tap-water and standard chow (standard diet - SD - 
energy 3.3kcal/g, fat 17%, carbohydrate 60 % and protein 23 % provided by 
Altromin-R, Rieper, Italy) were continuously available until 5 weeks of age.  
3.2.2. Diet administration 
At 5 weeks of age, all females (n= 77) were fed ad libitum either with a 
hypercaloric (high-fat diet- HFD - energy 5.56 kcal/g, fat 58%, carbohydrate 
25.5% and protein 16.4%; n= 43) or a control diet (CD - energy 4.07 kcal/g, fat 
10.5%, carbohydrate 73.1% and protein 16.4%; n= 34) for 13 weeks, i.e. until 
right before delivery. Females were randomly assigned to HFD or CD groups 
avoiding difference in the average of body weight between groups. Obesogenic 
(D12331) and Control (D12328) diets were be provided by Research Diets, Inc., 
New Brunswick, NJ, USA.  
3.2.3. Antioxidant administration 
After 5 weeks on the diets, all females underwent antioxidant treatment with 
NAC, for 5 weeks, until the end of dietary treatment. NAC (Sigma-Aldrich) was 
daily administered in drinking water (Balansky et al., 1996), in order to 
minimize stress due to excessive handling procedure by the experimenter, to 
yield an average dose of 1 g NAC/kg body weight.  
3.2.4. Breeding procedure 
At 15 weeks of age, after 10 weeks on the diet and 5 weeks of NAC 
administration, all females were bred. In order to optimize reproductive success 
 71 
of experimental females, a handful of sawdust from a male’s cage was added to 
the females’ cages every morning for 3 days, so that males’ pheromones from 
dirty sawdust (urine) induced the estrus cycle (also known as Whitten effect) 
(Brockman et al., 1998). On the 4th day, a male was introduced in each cage and 
females were checked twice a day for the presence of a vaginal plug to 
tentatively confirm pregnancy. If a vaginal plug was observed, the male was 
removed from the females’ cage. When the vaginal plug was not observed the 
male were kept in the females’ cage for 10 days and the body weight was 
weekly checked. 
After mating, dams were kept with either HFD or CD and NAC 
throughout gestation until 3 days before the expected delivery date, that is at the 
gestational day 16 (G16). At this data, the antioxidant treatment (NAC) was 
stopped and all dams were shifted on SD. 
Body weight gain was monitored once a week throughout the 5 weeks 
of combined exposure to HFD and NAC. Birth success was also registered. 
Pups birth was considered as post-natal day 0 (P0). At P3 pups’ weight was 
registered, as well as at P30, when all pups were also weaned onto SD. At 3 
months of age, offspring of both genders were weighed and tested to assess the 
metabolic and emotional profiles resulting from prenatal exposure to a 
hypercaloric diet and the role of antioxidants on these regulations.  
A schematic design of the experimental plan is reported in Figure 1.  
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Figure 1. Schematic design of the experimental plan. 
 
 
Animal handling and experimental procedures were performed in 
accordance with the EC guidelines (EC Council Directive 2010/63/UE ) and 
with the Italian legislation on animal experimentation (Decreto L.vo 26/2010). 
 
3.3. EXPERIMENTAL PROCEDURE 
 
3.3.1. Metabolic regulation 
• Glucose tolerance test (GTT). Intra-peritoneal GTT was performed after a 15 h 
overnight fasting that took place from 06:30 p.m. until 09:30 a.m. Animals were 
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intra-peritoneally (IP) loaded with 2 g/kg body weight D-glucose (10% D 
glucose solution; Sigma, St. Louis, MO, USA) (Satapathy et al., 2011). Blood 
was collected from the tail vein at 0 (baseline), 30, 60, 120, and 180 min 
(Ranieri et al., 2010) following IP injection and glycemia (blood glucose 
concentration) was measured using a commercial glucometer (StatStrip Xpress-
i, nova biomedical, A. Menarini diagnostic) (Titta et al., 2010). 
• Insulin sensitivity test (IST). The test was performed on animals starved for 5 
h that took place from 09:30 a.m. until 02:30 p.m. Glycemia was measured 
using a commercial glucometer (StatStrip Xpress-i, nova biomedical, A. 
Menarini diagnostic) immediately before (0) and 15, 30, 60, 120 min after IP 
injection of a 0.4 U/kg body weight (Titta et al., 2010) solution of human 
recombinant insulin (Humulin, Eli-Lilly, 100 U/mL) (Ranieri et al., 2010). 
 
3.3.2. Behavioral phenotype 
After 5 days of washout from the manipulation required by the assessment of 
metabolic regulation, all subjects underwent behavioral testing to assess 
spontaneous behavior in the Open Field test, in addition to emotionality and 
general anxiety in the Elevated Plus Maze test (Pellow et al., 1985; File, 1993). 
These two tests were performed on different days. 
• Open field (OF). Each subject was individually placed in the center of a cubic 
arena (open field box 40×40×40 cm) made of Plexiglas and allowed to freely 
explore for a single session lasting 15 min. The OF box was ideally divided into 
25 squares and ideally partitioned into a central portion (24×24 cm) and a 
peripheral one, identified as the remaining part of the arena. When data were 
analyzed, the session was subdivided in three time blocks (tb), lasting 5 min, 
and the time spent in each portion of the arena was measured. Furthermore, the 
frequency of sniffing and rearing was scored as index of exploratory behavior 
and the latency and frequency of immobility were considered as index of 
emotional profile. Grooming frequency and the latency to the first event was 
also taken into account, providing a reliable marker of high or low stress in 
specific behavioral context (Katz and Roth, 1979; Kalueff and Tuohimaa, 
2005). 
• Elevated plus maze (EPM). The EPM is made of two open arms (30×5×0 cm) 
and two closed arms (30×5×15 cm) that extended from a common central 
platform (5×5 cm). The apparatus, made of Plexiglas (gray floor, clear walls), is 
elevated to a height of 60 cm above the floor. Mice were individually placed on 
the central platform facing an open arm and allowed to freely explore the maze 
for 5 min. Behavioral parameters observed were: % open entries [(open/total) × 
100] and time spent in the open and closed arms of the maze (File, 2001). 
Furthermore, the behavioral parameters taken into account were the frequency 
of head-dipping and of explorative behavior such as sniffing and locomotion 
(crossings of squares limits with all paws).  
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In both behavioral tests, after each session, the apparatus was cleaned 
with 50% ethanol to reduce olfactory cues. 
At 9 weeks of age mice began the experimental procedure. All subjects 
underwent the GTT as first metabolic test and after 3 days, in which mice were 
left undisturbed, all of them were tested for the IST. This time interval was 
necessary to recover from the fasting and the handling procedures. After 5 days 
from the end of the metabolic measurement subjects underwent the behavioral 
tests. 
 
3.3.3. Statistical analysis 
Data were analyzed using parametric analysis of variance (ANOVA) with 
treatment (NAC vs. WATER), maternal diet (HFD vs. CD) and gender (females 
vs. males) as between-subjects factors and minutes, zones (EPM: “center” vs. 
“closed arms” vs. “open arms” and OF: “center” vs. “periphery”) and time 
blocks (0-5 vs. 5-10 vs. 10-15 min) as within-subjects repeated measures, when 
appropriate (GTT, IST, EPM and OF tests).  
Post hoc comparisons have been performed using the Tukey’s test. In 
analyzing GTT and IST data, this test was used in the absence of significant 
ANOVA effects according to the indications given by Wilcox (Wilcox et al., 
1987). Fisher’s exact probability test was used to compare treatment and diets 
for reproductive success of the colony (i.e., number of pregnant females able to 
successfully deliver pups: two-by-two contingency table). Statistics were 
performed with Statview II (Abacus Concepts, CA, USA). 
 
3.4. RESULTS 
 
3.4.1. Dams’ body weight  
Overall, feeding a HFD determined an increase in body weight in the dams 
(main effect of diet: F(1,73)= 16.080; p= 0.0001). While no main effect of NAC 
was registered on body weight (F(1,73)= 0.75; p= 0.3893), an interaction between 
NAC and diet was found over weeks (F(5,365)= 4.166; p= 0.0011), with NAC 
inducing a gaining in body weight of CD females, rendering them more similar 
to HFD females, especially in the last week of combined exposure to HFD and 
NAC. 
 
3.4.2. Reproductive success 
No main effect of both NAC and HFD was found to affect reproductive success 
of females (Fisher’s exact probability test: p= 0.5554 and p= 0.2368, for NAC 
and HFD, respectively). In addition, despite NAC administration, HFD females 
were characterized by a reduced reproductive success than CD (Fisher’s exact 
probability test: p= 0.05). 
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3.4.3. Body weight of the offspring 
Regardless of maternal diet, offspring prenatally exposed to antioxidant 
treatment were characterized by a higher birth weight than controls (main effect 
of NAC: F(1,30)= 3.955, p= 0.05, Figure 2A), an effect also maintained when 
young adult, at 3 months of age, regardless of diet and gender (main effect of 
NAC: F(1,121)= 22.485, p< 0.0001, data not shown). At this age the interaction 
among maternal diet, NAC and gender resulted to not affect the body weight of 
the offspring (F(1,121)= 1.429, p= 0.2342, Figure 2C). In addition, while 
maternal HFD did not result in increased offspring’s body weight at birth and 
when young adult (main effect of maternal diet: F(1,30)(1,121)= 0.560; 1.730, p= 
0.4602; 0.1909, respectively at P3 and at three months of age), prenatal 
exposure to that increased offspring’s body weight at P30 (main effect of 
maternal diet: F(1,76)= 4.391, p= 0.0395, data not shown). At this age an 
interaction among maternal diet, NAC and gender has been also found with 
NAC contributing to increased body weight in HFD male mice (F(1,76)= 4.473, 
p= 0.0377, Figure 2B). 
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3.4.4. Metabolic regulation 
• Glucose tolerance test (GTT). Overall, gender resulted to strongly affect the
metabolic response to a glucose challenge, with male subjects being 
characterized by increased glycemia, suggesting reduced glucose tolerance 
(main effect of gender: F(1,105)= 18.487, p< 0.0001, data not shown). Given the 
significant difference between genders, a finer analysis was performed in order 
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to better investigate the metabolic response to glucose in male and female 
subjects independently. 
When individually analyzed, overall, prenatal exposure to maternal 
HFD and NAC independently affected the metabolic response in an opposite 
manner in the two genders. In detail, maternal HFD led to glucose sensitivity in 
females (main effect of maternal diet: F(1,25)= 4.546, p= 0.0430, data not 
shown), while did not affected metabolic response in males (main effect of 
maternal diet: F(1,59)= 0.051, p= 0.8218, data not shown). On the contrary, 
prenatal exposure to NAC induced glucose tolerance in males (main effect of 
NAC: F(1,59)= 6.751, p= 0.0118, data not shown), while no metabolic effects 
were observed in females (main effect of NAC: F(1,25)= 0.007, p= 0.9359, data 
not shown).  
In male mice, despite not being statistically significant (interaction 
between maternal diet, NAC and minutes: F(4,236)= 1.209; p= 0.3078, Figure 
3A), post-hoc comparison confirm that prenatal exposure to NAC led to glucose 
tolerance in CD males but was not able to counteract the HFD-induced glucose 
sensitivity (post-hoc comparison: NAC-CD vs. NAC-HFD and NAC-CD vs. 
WATER-CD, p< 0.01).  
In female mice, no effect of the interaction among maternal diet, NAC 
and minutes was observed in response to metabolic stimulus with glucose in 
females (F(4,100)= 0.990; p= 0.4168, Figure 3B). 
• Insulin sensitivity test (IST). Unlike to glucose, no difference in the metabolic 
response has been registered between genders after  an insulin challenge (main 
effect of gender: F(1,102)= 2.892, p= 0.0921, data not shown). 
As for the GTT, also in the IST an independent statistical analysis was 
run for the two genders. 
In male mice prenatal exposure to HFD led to insulin resistance (main 
effect of maternal diet: F(1,63)= 18.744, p< 0.0001) and, overall, prenatal NAC 
exacerbated this response (interaction between maternal diet and NAC: F(1,63)= 
5.279, p= 0.0249). Nonetheless, a main effect of prenatal NAC was not found 
(F(1,63)= 3.008, p= 0.0877). Moreover, despite no statistically significant 
(interaction among maternal diet, NAC and time course: F(4,252)= 0.911, p= 
0.4582, Figure 3C), post-hoc comparison confirm that prenatal exposure to 
NAC exacerbated insulin resistance characterizing HFD male mice in particular 
after 15 and 30 minutes after insulin injection (post-hoc comparison: NAC-HFD 
vs. NAC-CD and NAC-HFD vs. WATER-HFD, p< 0.01). 
In females no main effect of both maternal diet and NAC was registered 
(main effect of maternal diet and NAC: F(1,39)= 0.311; 0.962, p= 0.5805; 0.3327, 
respectively). In addition, no significant difference in the glycemic response to 
insulin was registered among experimental groups over time (interaction among 
maternal diet, NAC and minutes: F(4,156)= 0.862, p= 0.4884, Figure 3D).  
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Figure 3. Metabolic regulation. Glucose tolerance assessment in male (A) and female (B) 
offspring exposed to maternal CD or HFD and NAC. Insulin sensitivity test male (C) and female 
(D) offspring exposed to maternal CD or HFD and NAC. Data are shown as ± s.e.m. Post-hoc 
comparisons, ∗∗ p< 0.01. Experimental subjects; GTT: cd-water-f/m, n= 10/19; cd-nac-f/m, n= 
7/19; hfd-water-f/m, n= 10/20; hfd-nac-f/m, n= 2/5; IST: cd-water-f/m, n= 17/22; cd-nac-f/m, n= 
6/19; hfd-water-f/m, n= 18/22; hfd-nac-f/m, n= 2/4. 
 
 
3.4.5. Behavioral phenotype 
• Open field (OF). Overall, all mice spent significantly less time in the center of 
the arena (main effect of zone: F(1,63)= 2604.056, p< 0.0001, data not shown), in 
particular mice prenatally exposed to maternal HFD (interaction between 
maternal diet and zone: F(1,63)= 12.278, p= 0.0008, data not shown). On the 
contrary, prenatal exposure to NAC resulted in increased time spent in the 
center of the open field in all subjects (interaction between NAC and zone: 
F(1,63)= 64.581, p< 0.0001, data not shown), being also able to counteract the 
effect of maternal HFD, as demonstrated by the interaction among maternal 
HFD, NAC and zone (F(1,63)= 3.742, p= 0.05, Figure 4A).  
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While no difference has been registered as a result of HFD (main effect 
of maternal diet: F(1,63)= 0.108; 0,111, p= 0.7439; 0.7400, respectively for 
frequency of sniffing and rearing), prenatal exposure to NAC determined an 
increased exploratory behavior, as indicated by the increased frequency of 
environmental sniffing and rearing (main effect of NAC: F(1,63)= 4428.106; 
10.390, p< 0.0001; p= 0.0020, respectively for frequency of sniffing and 
rearing), in particular in females, being more explorative than males 
(interaction between NAC and gender: F(1,63)= 9.237, p= 0.0035, for frequency 
of sniffing).  
Overall, mice prenatally exposed to NAC were characterized by higher 
latency and reduced frequency of immobility than controls (main effect of NAC: 
F(1,63)= 21.422; 20.966, p< 0.0001; p< 0.0001, respectively for latency, Figure 
4B, and frequency). Interestingly, while no main effect of maternal diet was 
observed (F(1,63)= 0.001, p= 0.9811, data not shown), HFD increased emotional 
response in a context of novelty in male mice, as indicated by the lower latency 
to immobility than both CD males and HFD females (interaction between 
maternal diet and gender: F(1,63)= 7.428, p= 0.0083, data not shown).  
In addition, regardless of maternal diet and gender, prenatal exposure to 
NAC increased frequency of grooming and reduced the latency to the first 
episode (main effect of NAC: F(1,63)= 51.151; 19.246, p< 0.0001; p< 0.0001, 
respectively for frequency and latency). 
• Elevated plus maze (EPM). Overall, all subjects spent more time in the closed 
arms of the apparatus (main effect of zone: F(1,63)= 7.534, p= 0.0079, data not 
shown).  
In addition, no difference was registered in % time spent in the open 
arms of the apparatus in response to both HFD and NAC independently (main 
effects: F(1,63)= 0.852; 2,020, p= 0.3595; 0,1602, respectively for HFD and 
NAC). Although not affecting % time spent in open arms, prenatal exposure to 
NAC resulted in increased emotionality, as indicated by increased latency to 
first enter in the open arms of the apparatus (main effect of NAC: F(1,63)= 6.479, 
p= 0.0134), particularly in offspring exposed to maternal HFD in utero 
(interaction between maternal diet and NAC: F(1,63)= 7.961, p= 0.0064, Figure 
4C) and by the reduced frequency of head-dipping behavior (main effect of 
NAC: F(1,63)= 12.448, p= 0.0008, Figure 4D).  
Moreover, regardless of both maternal diet and gender, NAC also 
increased exploratory behavior as indicated by the increased frequency of 
environmental sniffing (main effect of NAC: F(1,63)= 14.334, p= 0.0003, data not 
shown) and by increased locomotion, particularly in female mice (interaction 
between NAC and gender: F(1,63)= 13.575, p= 0.0005, data not shown). 
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Figure 4. Behavioral phenotype. Time spent in zone of the arena (A) and latency to first 
immobility (B) in the Open Field test. Latency to first enter in open arms of the maze (C) and 
frequency of head-dipping behavior (D) in the Elevated Plus Maze test. Data are shown as + 
s.e.m. Post-hoc comparisons, ∗∗ p< 0.01 (nac-hfd vs. water-hfd; nac-cd vs.water-cd; nac 
vs.water); ∗ p< 0.05 (hfd-nac vs. hfd-water and cd-nac). Experimental subjects: water-cd/hfd-f/m, 
n= 12; nac-cd-f/m, n= 7/10; nac-hfd-f/m, n= 2/4. 
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3.5. DISCUSSION 
 
Overall, results from this study support previous data showing that maternal 
HFD represents a detrimental metabolic stimulus for both the dam and the 
offspring. This is confirmed by the failure of NAC treatment to restore the 
reproductive success lacking in HFD female mice. The most relevant finding is 
the action of the NAC drug, which replicate the metabolic effect of the p66Shc 
gene deletion, conferring glucose tolerance and insulin resistance to young adult 
male offspring. Interestingly, maternal HFD and NAC differently affect the 
metabolic phenotype of the offspring of both genders suggesting a long-lasting 
and gender-dependent effect. Moreover, prenatal NAC overturned the effect of 
maternal HFD on the emotional and behavioral phenotype of the offspring. 
As previously found, lasting feeding a HFD induced a gaining in body 
weight in females (Bellisario et al., 2014). In addition, NAC induced a gaining 
in body weight in controls female mice only, suggesting that the potential effect 
as a dietary supplementation is particularly evident in standard dietary condition 
and that this effect could be covered by the stronger effect of a HFD.  
Moreover, results from this study indicate that prenatal antioxidant 
treatment missed to thwart reproductive failure characterizing HFD-fed dams. 
Several studies have shown delivery failure in addition to fetal resorption during 
gestation in female rats fed a HFD diet (Niculescu and Lupu, 2009), suggesting 
a detrimental action to embryo development due to high OS. This hypothesis is 
further supported by previous findings in a transgenic mouse model of reduced 
OS, the p66Shc-/- mouse. This phenotypic feature played a protective role in 
reproductive failure associated to maternal HFD (Bellisario et al., 2014), 
furthermore suggesting that antioxidant administration (NAC) did not exert a 
comparable effect with a more effective genetic condition. Indeed, pregnancy is 
a physiological condition in which body unexpectedly responds to both 
endogenous and exogenous stimulus and in which hormonal stimulation is 
potentiated. Taking into account such evidences, prenatal exposure to NAC is 
not enough to induce the expected protective effect. 
Taking into account the offspring, as already observed in the transgenic 
model of resistance to OS (the transgenic mouse model p66Shc-/-), prenatal NAC 
resulted in increased birth weight of the offspring. This could represent an offset 
effect toward the reduced birth weight usually associated to prenatal HFD. 
Interestingly, a comparable profile between the genetic and the pharmacological 
model of reduced OS used in this study was also found in body weight at P30, 
when maternal HFD resulted in a greater gain in body weight only in males also 
prenatally exposed to NAC, as was previously found in the p66Shc-/- mice only. 
A previous study performed by White and co-workers on rats showed that 
offspring of maternally obese dams weighed significantly more than the 
offspring of non-obese dams at weaning (White et al., 2009). The prenatal 
exposure to an antioxidant seemed not to be able to counteract the effect of 
maternal HFD while, on the contrary, to potentiate its effect on weight gain in 
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the offspring at weaning age. This effect might be due to the evidence that the 
weaning age is a critical period in which several physiological adjustments 
occur, resulting in significant consequences for the offspring with behavioral 
and hormonal changes defining the growing individual (Lhuillery et al., 1984; 
Martin et al., 1984). In this context the prenatal exposure to maternal HFD 
might major impact the ticklish weaning age. The current study did not found 
effects in offspring body weight at three months of age as a consequence of 
maternal consumption of HFD. Interestingly, this feature has been previously 
reported by Platt and colleagues in a mouse model of maternal HFD (De Flora 
et al., 1995a). They found that the differences in lard pup weight registered 
before weaning disappeared after that age, proposing several explanations, 
among the others a greater content of sucrose in control diet compared to the 
hypercaloric diet. This variation of sucrose in the diets could have masked 
potential differences in offspring body weight after weaning in growing 
offspring (De Flora et al., 1995a). Similarly, the diets used in the present study 
provided a different calorie intake in fats and carbohydrates, which are 
respectively 58% fat and 25.5% carbohydrate for the HFD and 10.5% fat and 
73.1% carbohydrate for CD. Despite the same kinds of diet were used in a 
previous study inducing a significant increasing in body weight, both at 
weaning and at three months of age in HFD offspring, it is possible hypothesize 
that prenatal exposure to NAC metabolically interfere with the maternal diets 
thus eclipsing the effect of HFD and resulting in a mild metabolic outcome in 
the offspring body weight.  
Moreover, the effects of prenatal exposure to maternal HFD in 
combination with prenatal NAC have been tested by measuring the 
responsiveness to metabolic exogenous stimuli, those are glucose and insulin. 
Data shows that prenatal exposure to maternal HFD and NAC differently drive 
the metabolic response to a bolus of glucose in young offspring of both genders. 
Male mice prenatally exposed to NAC show a greater resistance toward glucose 
challenge compared to controls. However, such effect was lost in males 
prenatally exposed to HFD, being characterized by severe glucose intolerance in 
comparison with their own controls (NAC-CD) and suggesting that prenatal 
exposure to NAC is not enough able to counteract the negative metabolic effect 
driven by maternal HFD. The increased resistance to a glucose challenge 
showed by NAC males is supposedly due to the reduced oxidative stress 
associated to pharmacological treatment. Previous data showed that the 
metabolic profile induced by a glucose challenge is strictly similar in NAC 
subjects and in p66Shc-/- genetic mouse model of reduced OS (Bellisario et al., 
2014). Accordingly, when tested in the insulin sensitivity test, prenatal NAC 
exacerbated the insulin resistance characterizing HFD male mice, as the lack of 
the p66Shc gene also done. The evidence of a comparable metabolic action 
between the pharmacological treatment and the genetic condition is given by the 
glycaemic trend of NAC subjects in response to metabolic stimuli perfectly 
following that characterizing the genetic model of reduced OS. These features 
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strongly suggest that the effect of prenatal NAC mimics the lack of p66Shc gene 
on the metabolic response. It is interesting to note that a completely different 
metabolic profile has been registered in females, in which prenatal NAC did not 
mainly affect the metabolic response neither to glucose or insulin. In addition, 
maternal HFD driven a greater glucose resistance in females, while did not 
affect males’ response, and, on the contrary, induced a greater insulin resistance 
in males did not affecting females metabolic profile. These data confirm 
previous data related to a gender-dependent resiliency metabolic challenges 
following prenatal exposure to high-fat diet (Bellisario et al., 2014).  
As concerning the behavioral profile, in the open field test, HFD 
offspring spent less time in the center of the arena, suggesting an HFD-induced 
anxiety-like profile. Indeed, the open field test, in addition to reflect deficits in 
motor behavior, is appropriately used to test partial anxiety (Sharma et al., 
2010). Previous studies have reported increased anxiety-like behavior in adult 
subjects of both genders exposed to HFD during fetal development (Sasaki et 
al.; Bilbo and Tsang, 2010; Peleg-Raibstein et al., 2012), although in some 
cases a gender dependent effect is reported (Bilbo and Tsang, 2010). In line 
with the latter finding, we observed reduced latency to immobility, considered 
an endpoint of anxiety-like behavior, characterizing HFD males compared to 
CD male and HFD females. More interesting prenatal NAC is able to counteract 
the anxiogenic effect of maternal HFD increasing the time spent in the center of 
the arena both in HFD and CD mice and increasing latency and reducing 
frequency of immobility. A similar effect was also found by Chen and 
colleagues, which found NAC improved social interaction and ameliorated 
anxiety-like behaviors in the valproate-exposed male offspring of a rat model of 
autism (Chen et al. 2014). Prenatal exposure to NAC also resulted in increased 
frequency of grooming. Nevertheless some reports grooming as an anxiety 
related behaviors and an increased frequency of these events as a greater level 
of anxiety (Lister, 1990), others state that grooming behavior might just 
represent a displacement response (Espejo, 1997a, 1997b) that may be essential 
to restore homeostasis (Kalueff and Tuohimaa, 2005) after exposure for the first 
time to a novel environment. Also, it has been stated that rodents’ grooming 
activity occurs under conditions of extreme arousal, in both high and low stress 
situations (Katz and Roth, 1979; Kalueff, 2000). Interestingly, prenatal 
exposure to NAC leads to increased exploratory behavior both in the open field, 
as suggested by the increased frequency of sniffing and rearing, and in the 
elevated plus maze, as suggested by increased frequency of environmental 
sniffing and increased locomotion, in particular in females. Unlike to the 
reduced emotionality found in the open field, in the elevated plus maze NAC 
subjects showed increased emotionality as indicated by the reduced frequency 
of head-dipping behavior. It is generally accepted that increased exploratory 
head dipping behavior in the open arms of the apparatus is an index of 
decreased levels of anxiety (Blanchard et al., 2001). 
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Overall, results from this study confirm the negative effect associated to 
maternal HFD for both the dam and the offspring. In addition, the present work 
mainly investigated the potential effect of a synthetic antioxidant administered 
during the prenatal life, the N-acetyl-cysteine, to thwart the effect of maternal-
HFD and supposedly associated to the resulting increased oxidative stress. In 
this regard, results obtained in the present study indicated that prenatal 
antioxidant administration is able to limit some long-term consequences 
deriving from HFD exposure during fetal development. It is possible 
hypothesize that this effect is due to the contemporary exposure to both stimuli, 
thus rendering the antioxidant action more efficacy because working on the 
developing fetus in the attempt to reduce the fetal misprogramming. The main 
effect of prenatal NAC was observed in the metabolic phenotype characterizing 
the young adult offspring, in particular in males, confirming a gender-dependent 
metabolic sensitivity maybe driven by hormones. The most important result is 
that the prenatal exposure to antioxidants mimics some of the effects of the 
genetic mouse model of reduced oxidative stress, the p66Shc gene knock out, 
particularly on the metabolic response. This partial effect may be associated to 
the short time window of exposure that could not be compared with a stable 
genetic condition. This finding highlights the key role played by oxidative stress 
in the metabolic response thus representing an important target for future 
studies investigating potential therapeutic interventions to precociously stop the 
long-term detrimental effect of the maternal HFD experienced early in life. 
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ABSTRACT 
Maternal diet during pregnancy can impact maternal behavior as well as the 
intrauterine environment, playing a critical role in programming of the 
offspring’s physiology. In a preliminary study we found a strong association 
between high-fat diet (HFD) during pregnancy and increased cannibalistic 
episodes and dams’ mortality during late pregnancy and parturition. Therefore, 
we hypothesized that HFD during pregnancy could negatively affect 
neuroendocrine and metabolic regulations occurring during the final stages of 
pregnancy, disrupting maternal behavior. To test such hypothesis, female 
C57BL/6J mice were fed HFD or control diet before and during pregnancy up 
to delivery. Neuroendocrine and molecular endpoints were assessed at different 
time points, both in the mothers and in the pups. More in detail, Hypothalamic-
Pituitary-Adrenal (HPA) axis activity and the levels of c-Fos in the olfactory 
bulbs were measured, in addition to peripheral leptin levels. Dam’s emotional 
behavior and social anxiety, in addition to maternal locomotor activity were 
assessed before parturition. Maternal behavior was also evaluated on post-natal 
day 1. Placental levels of 11-β-dehydrogenase-2 (11-βHSD2) and 11-β-
dehydrogenase-1 (11-βHSD1), regulating fetal exposure to maternal 
glucocorticoids, were also assessed. HFD led to an increased rate of 
cannibalism and to an aberrant maternal behavior, with dams showing 
behavioral uninhibition and locomotor activity, in addition to an overall reduced 
expression of c-Fos in the olfactory bulbs. HFD-feeding resulted in increased 
levels of maternal corticosterone and decreased levels of leptin, in addition to 
reduced enzymatic activity of 11β-HSD2 and reduced levels of the 11β-HSD1 
gene expression in the placenta. Overall, these data suggest that HFD acts as a 
stressful challenge during pregnancy, impairing the neuroendocrine system and 
the neural activity of brain regions involved in the processing of relevant 
olfactory stimuli, with aberrant consequences on mother’s physiology and 
maternal behavior. 
Keywords: high-fat diet, pregnancy, maternal behavior, anxiety, stress, 
biomarkers, animal models. 
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4.1. INTRODUCTION 
 
In modern society, a diet rich in fats (high-fat diet - HFD) is an example of a 
physiological stressor experienced by women during pregnancy (Reynolds et 
al., 2013). High-fat feeding during pregnancy causes placental dysfunction 
(McCurdy et al., 2009; Frias et al., 2011) and plays an important role in fetal 
development promoting metabolic programming in the offspring with long-term 
detrimental effects on health during life (Drake and Reynolds, 2010; Li et al., 
2011). Maternal HFD during pregnancy “programs” lifelong susceptibility to 
adult disorders, representing a risk factor for psychiatric disease, such as 
depression and schizophrenia (Barker, 2004; Eriksson et al., 2004; Huizink et 
al., 2004), metabolic complications, such as insulin resistance (IR) and type 2 
diabetes (T2D), in addition to cardiovascular disease and other metabolic 
disorders usually associated with obesity (Kahn and Flier, 2000; Wang et al., 
2004; Fantuzzi, 2005; Taylor et al., 2006; Eriksson et al., 2014). It is well 
known that the environment experienced early during development is not only 
crucial for setting the growth trajectory of the fetus but also represents a key 
factor contributing to overall disease susceptibility in later life (Barker, 1995). 
In this context, developmental plasticity is a fundamental mechanism matching 
the growing organism to the environment it will face after birth (Barker, 2003).  
Preclinical studies have shown that extreme changes in maternal diet 
influence maternal stress responses in rats (Weinstock, 2001). In particular, the 
administration of a HFD causes the sensitization of the hypothalamic-pituitary-
adrenal (HPA) axis (Legendre and Harris, 2006) resulting in increased basal 
levels of maternal glucocorticoids associated with increased emotionality 
(Tannenbaum et al., 1997; Boukouvalas et al., 2008). The activity of the 
maternal HPA axis undergoes physiological adaptations in order to achieve 
regular development of the fetus avoiding adverse effects on both mother and 
offspring (Duthie and Reynolds, 2013). In turn, the fetus is protected from high 
glucocorticoids levels by the activity of specific placental enzymes, 11β-
hydroxysteroid dehydrogenase (11β-HSD) type 1 and 2, acting as a placental 
barrier, which regulates the transfer of glucocorticoids from mother to fetus 
(Benediktsson et al., 1997; Holmes et al., 2006). 
In a previous study we found that maternal HFD-feeding during 
pregnancy has detrimental effects both on the dam, increasing cannibalistic 
episodes and dam mortality rate in the perinatal period, and on the offspring, 
with long-lasting and gender-dependent effects on metabolic and 
neuroendocrine profile at adult age (Bellisario et al., 2014). Clinical studies and 
animal models have reported altered placental growth, gene expression and 
nutrient transport following HFD feeding during pregnancy (Jones et al., 2009; 
Farley et al., 2010; Gallou-Kabani et al., 2010; Gabory et al., 2012). 
Nevertheless, data concerning the mechanistic effects of HFD on the 
physiological adaptations occurring during the perinatal period are still lacking.  
 92 
Understanding the maternal physiological alterations driven by HFD 
during pregnancy is of major public health importance, and could provide 
predictive factors of susceptibility for maternal HFD-related metabolic and 
mood disorders reported in the adult population. Given the abundance of dietary 
fats in western diets, these are important public health issues.  
The current study aimed at investigating the effects of high-fat feeding 
before and during pregnancy on the neuroendocrine, metabolic and behavioral 
profile of dams in the perinatal period, both before and after delivery, with a 
special focus on the effects of HFD on the molecular adaptation associated with 
parturition, delivery and on the onset of maternal behavior. We hypothesized 
that HFD-feeding could represent a metabolic, stressful challenge during 
pregnancy able to negatively affect physiological adaptation occurring during 
perinatal period and the maternal behavior. To test such a hypothesis, C57BL/6J 
female mice were fed with HFD or control diet (CD) for 11 weeks: from 5 
weeks of age until the onset of delivery. Neuroendocrine activation and levels 
of c-Fos in the olfactory bulbs were measured both before and after delivery. 
The behavioral profile of dams and maternal behavior towards the pups was 
characterized, in addition to leptin levels in adipose tissue. Furthermore, the 
modulation of fetal exposure to glucocorticoids was also determined. 
 
4.2. MATERIALS AND METHODS 
 
4.2.1. Animals 
Experimental subjects were 5 week-old C57BL/6J females (n= 100) and same 
strain experienced male mice (n= 34). Females were housed 3/cage and males 
were individually housed in transparent Plexiglas cages (37×21×19cm) 
provided by Tecniplast, in an air conditioned room (temperature 21±1°C, 
relative humidity 60±10%) under a reversed 12/12hrs light/dark cycle with 
lights off from 07:00 a.m. to 07:00 p.m. Fresh tap-water and standard chow 
(standard diet -SD- energy 3.3kcal/g, fat 17%, carbohydrate 60% and protein 
23%, provided by Altromin-R, Rieper, Italy) were continuously available 
during the 7 days of habituation before the experimental procedure took place. 
Thereafter females were fed ad libitum either with high-fat diet (HFD - energy 
5.56 kcal/g, fat 58%, carbohydrate 25.5% and protein 16.4%; n= 50) or control 
diet (CD - energy 4.07 kcal/g, fat 10.5%, carbohydrate 73.1% and protein 
16.4%; n= 50) for 8 weeks. Females were randomly assigned to HFD or CD 
groups avoiding difference in the average of body weight between groups. HFD 
(D12331) and CD (D12328) were provided by Research Diets, Inc., New 
Brunswick, NJ, USA. During the 8 weeks on diet food consumption (daily) and 
body weight gain (weekly) of females was monitored and thereafter all females 
were bred (for the breeding procedure see paragraph 4.2.2.1). Pregnant females 
were kept on either HFD or CD throughout gestation until 3 days before the 
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expected delivery date, i.e. at gestational day 16 (G16), when all of them were 
switched to SD.  
Animals were handled consistently by the same personnel and 
manipulations were performed under red light. Noise and disturbances to the 
animals were kept to a minimum during the mating protocol, except for 
husbandry requirements and the procedures detailed below.  
Animal handling and experimental procedures were performed in 
accordance with the EC guidelines (EC Council Directive 86/609 1987) and 
with the Italian legislation on animal experimentation (Decreto L.vo 116/92). 
 
4.2.2. Experimental procedure 
4.2.2.1. Breeding procedure 
After 8 weeks on diet, a handful of sawdust from a male’s cage was added to a 
female’s cage every morning for 3 days, so that males’ pheromones from dirty 
sawdust (urine) induced the estrus cycle (Whitten, 1973). On the third day, one 
male was introduced into each female’s cage for 24 hours. Thereafter all 
females were checked twice daily to assess the presence of a vaginal plug (after 
8 hours at 06:00 p.m. and 24 hours at 10:00 a.m.) to tentatively confirm 
pregnancy. Body weight (BW) was monitored every 2 days to assess pregnancy. 
Females were individually housed once pregnancy was confirmed. 
The HFD feeding procedure and the breeding protocol previously 
described was also used in two different laboratories (the Centre for 
Cardiovascular Science, University of Edinburgh, UK and the Max Planck 
Institute of Psychiatry, Munich, Germany). In the present work data related to 
cannibalism also collected in these laboratories will be reported. No further data 
are available from these labs, due to the difficulties associated with breeding 
and parturition with the high-fat diet chosen for the study. 
 
4.2.2.2. Experimental groups 
Pregnant females (n= 73) were randomly assigned to four experimental groups 
for assessment of maternal levels of corticosterone (CORT) both before and 
after delivery, for in situ hybridization (ISH) determination on dams’ brain and 
for genetic, cellular and structural analysis on placentas, in addition to 
behavioral phenotyping of dams. The success of birth was also registered, in 
addition to the body weight of both fetuses and pups. 
• Group A (n= 8, for both CD and HFD) was designed to assess the prenatal 
levels of maternal CORT, at gestational day 16 (G16) (see paragraph 4.2.2.3). 
Thereafter all dams underwent a caesarean section procedure and whole brains 
were harvested and immediately frozen for gene expression analysis (see 
paragraph 4.2.2.5.). Moreover, two placentas, one for each side of the horn of 
uterus, were also collected and immediately frozen in order to assess the levels 
of the 11β-HSD2 enzyme (see paragraph 4.2.2.4.). 
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• Group B (n= 7, for both CD and HFD) was designed to assess the prenatal
levels of maternal CORT, on G18 (see paragraph 4.2.2.3). Thereafter all dams
underwent a caesarean section procedure. Two placentas, one for each side of
the horn of uterus, were also collected, weighed and immediately frozen for
the assessment of mRNA levels of 11β-hydroxysteroid dehydrogenase (HSD)-
1 placental gene (see paragraph 4.2.2.5.).
At this age a pool of fetal blood was collected for CORT determination 
and the placental and fetal weight was registered. The success of birth was also 
registered. 
• Group C (n= 8, for both CD and HFD) was designed for the assessment of
emotionality and social anxiety associated to pregnancy. In more detail, before
delivery females underwent behavioral tests aimed at assessing emotionality
(Elevated Plus Maze - EPM), at G16, and social anxiety (Social Avoidance
Test - SAT), at G17 (see paragraph 4.2.2.6). In addition, after parturition, on
post-natal day 1 (P1), all dams underwent to a Retrieval test assessing
maternal behavior and body weight of pups was also registered. After 24 hrs,
on P2, dams were sacrificed and whole brains and periovaric adipose tissue
were dissected out and immediately frozen for further analysis.
• Group D was designed to assess general activity associated to parturition (n=
8, for CD and n= 7 for HFD) and postnatal (P1) levels of maternal CORT (n=
8, for CD and n= 4 for HFD) (fsee paragraph 4.2.2.3). Thereafter, dams were
sacrificed and underwent to the same procedure also described for the group
A. Moreover, the abdominal fat tissue of mothers was collected for leptin
detection (see paragraph 4.2.2.3). The lower number of mice used in CORT
assessment was due to a technical hitch.
A schematic design of the experimental plan is reported in Figure 1. 
Figure 1. Schematic design of the experimental plan. 
 95 
4.2.2.3. Hormonal regulation 
• Metabolic response. The levels of leptin were assessed in the periovaric 
adipose tissue by immunoblot analysis. Adipose tissue pads (100 mg) were 
homogenized with Politron homogenizer in NaCl 150mM, Tris 25 mM pH 6.8, 
EDTA 1 mM, supplemented with protease and phosphatase inhibitors, and 
centrifugated 1000g for 10 min at 4°C, the fat pad fraction was discarded. A 
Bradford protein assay (Bio-Rad) was then conducted on the samples to 
determine the protein concentration for each sample. Proteins (20 mg) were 
separated by SDS-PAGE (10%) and transferred to nitrocellulose membrane. 
Membrane was blocked in 5% non-fat dry milk for one hour and incubated with 
primary antibody for one hour. Membrane was washed with TBS/0.1% Tween-
20 three times and incubated with secondary antibody for 1 hour, then washed 
with TBS/0.1% Tween-20 three times and reactivity was detected by the 
enhanced chemiluminescence kit (Pierce). Blots were developed using a 
FluorChem™ R System. Mouse monoclonal adiponectin and actin antibodies 
were from Abcam, Inc. (Cambridge, MA). 
• Neuroendocrine activation. The basal activity of the HPA axis of dams was 
assessed both before (G16 and G18) and after parturition (P1). In particular, CD 
and HFD dams underwent a blood samples collection by a tail nick at 08:30 
a.m., when the levels of circulating CORT were far from the circadian peak 
(Kitchener et al., 2004), in order to measure basal plasma levels of CORT (MP 
Biomedicals, LLC, Germany GmbH). The neuroendocrine activity of fetuses 
was measured as well. In detail, after the cesarean section procedure occurring 
at the 18th day of embryonic development (E18), trunk blood of all fetuses was 
pooled in order to determine the circulating levels of CORT. 
 
4.2.2.4. Enzyme activity 
11-β-HSD2 activity was measured in intact transfected cells after they were 
seeded in poly-D-lysine coated 96-well plates (25,000 cells/well) 24 h before 
the assay. The medium was removed, followed by addition of 40 l of fresh 
medium and 10 l that contained 10 nCi of radiolabeled cortisol or corticosterone 
and unlabeled corticosterone (20 to 500 nM) or cortisol (50 to 2000 nM). 
Reactions were incubated for 2 to 12 h at 37°C under 5% CO2. Kinetic analyses 
were performed by nonlinear regression using Data Analysis Toolbox (Elsevier 
MDL, San Ramon, CA), assuming first-order rate kinetics. 
 
4.2.2.5. Gene expression 
• rtPCR. Total RNA was extracted from tissue samples using TRIZOL reagent 
(Life Technologies Inc., Paisley, UK). Extracted RNA was treated with 
deoxyribonuclease I (Invitrogen, Paisley, UK) to remove contaminating 
genomic DNA. RNA (1 µg) was then reverse transcribed at 55 °C for 50 min 
using Moloney murine leukemia virus reverse transcriptase (Promega, 
Southampton, UK) according to the manufacturer’s instructions. Real-time PCR 
(rtPCR) was performed using the TaqMan ABI Prism 7900 sequence detector 
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(Applied Biosystems, Chester, UK). Expression levels were quantified using 
Lightcycler 480 Probes Master (Roche Diagnostics, Burgess Hill, UK) with 
primer probe sets (Applied Biosystems) for the 11β-HSD-1 gene. Data 
acquisition was performed using Sequence Detector 1.6.3. software (Applied 
Biosystems). A standard curve for each primer probe set was generated in 
triplicate by serial dilution of pooled cDNA. Each sample was run in triplicate, 
and the mean values of the triplicates were used to calculate transcript level 
from the standard curve. The results are expressed as a ratio to 18S rRNA to 
normalize the transcript levels. Reverse transcriptase negative controls and 
intron spanning primers were used where possible to prevent genomic DNA 
amplification. 
• In situ hybridization (ISH). Frozen brains were sectioned at -20°C in a cryostat 
microtome at 18 µm, thaw mounted on Super Frost Plus slides, dried and stored 
at -80°C. In-situ hybridization using a 35S UTP labeled ribonucleotide probes 
for c-Fos was performed as described previously (Schmidt et al., 2007). Briefly, 
sections were fixed in 4% paraformaldehyde and acetylated in 0.25% acetic 
anhydride in 0.1 M triethanolamine/ HCl. Subsequently, brain sections were 
dehydrated in increasing concentrations of ethanol. The antisense cRNA probes 
were transcribed from a linearized plasmid. Tissue sections were saturated with 
100 ml of hybridization buffer containing approximately 1.5×106 cpm 35S 
labeled riboprobe. Brain sections were coverslipped and incubated overnight at 
55 °C. The following day, the sections were rinsed in 2 × SSC (standard saline 
citrate), treated with RNAse A (20 mg/l) and washed in increasingly stringent 
SSC solutions at room temperature. Finally, sections were washed in 0.1×SSC 
for 1 h at 65 °C and dehydrated through increasing concentrations of ethanol. 
The slides were exposed to Kodak Biomax MR films (Eastman Kodak Co., 
Rochester, NY) and developed. Autoradiographs were digitized, and expression 
was determined by optical densitometry utilizing the freely available NIH 
ImageJ software. The mean of four measurements of two different brain slices 
was calculated for each animal. The data were analyzed blindly, always 
subtracting the background signal of a nearby structure showing no specific c-
Fos expression from the measurements. 
 
4.2.2.6. Maternal behavioral phenotype 
• Elevated plus maze (EPM). Three days before the expected delivery date 
(G16), dams of the group B underwent to EPM test. The apparatus is made of 
two open arms (30×5×0 cm) and two closed arms (30×5×15 cm) that extended 
from a common central platform (5×5 cm). The apparatus, made of Plexiglas 
(grey floor, clear walls), is elevated to a height of 60 cm above the floor. Mice 
were individually placed on the central platform facing an open arm were and 
allowed to freely explore the maze for 5 minutes. Behavioral parameters 
observed were: % open entries [(open/total) × 100] and % time spent in open 
and closed arms of the maze (File, 2001). Furthermore, the frequency of rearing 
was taken into account as a behavioral index of exploratory activity but that 
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may also be determined by emotionality (Gironi Carnevale et al., 1990; Thiel et 
al., 1998), providing a marker of anxiety. 
• Social avoidance test (SAT). Two days before expected delivery date (G17) 
dams underwent a SAT (Berton et al., 2006). Pregnant females were introduced 
in a plastic open field arena (42×42 cm), made of grey Plexiglas, for two 
consecutive sessions, 2.5 min each (a test duration chosen for its optimal 
sensitivity/throughput ratio (Berton et al., 2006)). During session I (“no target”), 
the open field contained an empty wire mesh cage (diameter= 10 cm, h= 10 cm) 
located in the middle of one side of the arena. During session II (“social 
target”), a social target (an unfamiliar CD-1 male mouse) was introduced into 
the wire mesh cage. Between the two sessions, the pregnant dam was placed 
back into its home cage for 1 min. The time spent in the “interaction zone” (8 
cm wide corridor surrounding the cage) vs. the “corners” (opposite to the 
location of the cage, 8×8 cm each) was scored as a reliable measure of social 
avoidance. The percent time spent in the interaction zone was considered as a 
reliable indicator of social avoidance.  
In all behavioral tests, both before and after each trial/session, the 
apparatus was cleaned with 50% ethanol to reduce olfactory cues which might 
compromise the result of the test. 
• Retrieval test. CD and HFD underwent a Retrieval test to assess maternal 
behavior. Dam and pups were removed from their home cage for 15 min and 
placed in two different clean holding cages. Pups were placed in an incubator in 
order to maintain an approximate body temperature of 30±1°C i.e. comparable 
to that of the nest (Cirulli et al., 2003; Capone et al., 2005). Thereafter, 4 pups, 
2 males and 2 females, were placed back in their home cage,  evenly distributed 
between the four corners, while the mother was introduced in the center of the 
cage. The latency to first sniffing a pup and to retrieve each pup was scored. 
The cut-off time was 20 min. Only pups brought into the nest were counted as 
retrieved. 
 
4.2.2.7. Locomotor activity 
A group of dams was housed in a special rack provided with motion sensors (n= 
8, for CD and n= 7 for HFD) and monitored for spontaneous locomotion over 
the three days preceeding the expected delivery date. Locomotor activity was 
monitored through an automatic device using small infrared sensors positioned 
on the top of each cage (ACTIVISCOPEsystem, NewBehaviour Inc., Zurich, 
Switzerland (Dell'Omo et al., 2002; Macri et al., 2013)). The sensors detected 
any movement of mice (except when mice were asleep or inactive) with a 
frequency of 20 events per second (20 Hz). Average scores obtained during 60 
min intervals, expressed as counts per hour, were recorded by an IBM computer 
with dedicated software. We averaged the data obtained during the three days 
before the expected delivery date (G16-G19) of continuous registration to 
obtain a circadian profile (23 points, 1h each) of locomotor activity. 
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4.2.3. Statistical analysis 
Data were analyzed using parametric analysis of variance (ANOVA) with diet 
(HFD vs. CD) as between-subjects factors and zones (“centre” vs. “closed arms” 
vs. “open arms”) and sessions (“no target” vs. “social target”) as within-subject 
repeated measures, where appropriate (EPM and SAT tests).  
Post hoc comparisons have been performed using the Tukey’s test. In 
analyzing SAT data, this test was used in the absence of significant ANOVA 
effects according to the indications given by Wilcox (Wilcox, 1987). The 
statistical 2-tailed T-test was used to assess variations by diets in genes’ 
expression (11-β-HSD-1 and c-Fos) and in enzymatic activity (11-β-HSD-2). 
Fisher’s exact probability test was used to compare diets for reproductive 
success of the colony (i.e. dam mortality rate during the perinatal period, 
number of litters in which cannibalistic episodes took place, pup mortality rate 
in the two days after delivery and number of dam retrieval rate in the Retrieval 
test: two-by-two contingency table). Statistics were performed with Statview II 
(Abacus Concepts, CA, USA). 
4.3. RESULTS 
4.3.1. Dams’ body weight and food consumption 
Female mice fed a HFD gained more body weight than CD (main effect of diet: 
F(1,98)= 129.883; p< 0.0001, insert Figure 2) through the 8 weeks of exposure 
(interaction between diet and weeks: F(8,784)= 94.851, p< 0.0001, Figure 2). 
Nevertheless, no difference in food consumption was not registered (main effect 
of diet: F(1,32)= 0.069, p= 0.7945, data not shown). 
Figure 2.Dams’ body weight. Body weight of dams during the 8 weeks of diet exposure and 
average of body weight gain (insert). Data are shown as +S.E.M. Post-hoc comparisons: ***p< 
0.001 (HFD vs. CD). Experimental subjects, CD/HFD, n= 50. 
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4.3.2. Pregnancy duration, cannibalistic behavior and pups’ mortality 
Female mice fed a HFD before and during pregnancy resulted in a prolonged 
pregnancy compared to CD (main effect of diet: F(1,15)= 14.412, p= 0.0018, 
Table 1A). 
Feeding HFD resulted in an increased frequency of cannibalistic 
episodes (Fisher’s exact probability test: p= 0.0351, Table 1B), which was not 
observed in CD mothers. An increased pups’ mortality associated to HFD was 
also registered (Fisher’s exact probability test: p< 0.0001, Table 1C1). These 
data were reinforced by further results obtained in a separate laboratory 
adopting the same protocol of diet feeding, the Centre for Cardiovascular 
Science at the University of Edinburgh (Fisher’s exact probability test: p= 
0.0001, Table 1C2). Data reported in table’s sections C1 and C2 refer to the 
number of pups found dead. Similar results were also found in the laboratory of 
the Max Planck Institute of Psychiatry, where an increased mortality in the HFD 
nests was registered (nests’ mortality: CD= 2, HFD= 15; nests’ surviving: CD= 
11, HFD= 2) (Fisher’s exact probability test: p= 0.0001, data not shown). 
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Table 1. Duration of pregnancy, pups’ mortality and cannibalistic behavior. Increased 
duration of pregnancy in females fed a HFD (A). High frequency of cannibalistic episodes in 
HFD dams (B) and an increased pup mortality rate in HFD nests (C) in two different laboratories 
involved in the study, at Istituto Superiore di Sanità, Rome, Italy (C1) and at Centre for 
Cardiovascular Science, University of Edinburgh, UK (C2). In the section A the table reports the 
average number of days of pregnancy ±S.E.M., in the sections B the table reports the number of 
dams on diet, in the sections C1 and C2 the table reports the number of pups. 
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4.3.3. Offspring body weight 
Overall, exposure to maternal HFD resulted in a decreased placental weight at 
the 18th day of embryonic development (E18) (main effect of diet: F(1,54)= 6.131, 
p= 0.0165, Figure 3A), in addition to a reduced fetal weight (main effect of 
diet: F(1,54)= 35.826, p< 0.0001, Figure 3B). Regardless of gender, this effect 
was lost after birth (P1), when no difference was registered in body weight of 
CD and HFD pups (main effect of diet: F(1,80)= 0.817, p= 0.3686). However, at 
this time, gender affected body weight, with females weighing less than males 
(main effect of gender: F(1,80)= 7.523, p= 0.0075, Figure 3C). 
 
 
 
 
Figure 3. Weight of placentas (A) and fetuses (B) at E18 and birth weight of pups (C). Data 
are shown as +S.E.M. Post-hoc comparisons: *p< 0.05 (HFD vs. CD); **p< 0.01 (fetus: HFD vs. 
CD; pups: HFD-f vs. CD-f). Experimental subjects: Placentas: CD/HFD, n= 28; Fetus: CD/HFD, 
n= 28; Pups: CD-f/m, n= 28/32, HFD-f/m, n= 14/10. 
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4.3.4. Hormonal regulation 
• Metabolic response. Overall, reduced levels of leptin were found in the
periovaric adipose tissue of females fed a HFD (main effect of diet: F(1,10)= 
5.029; p= 0.0488, Figure 4).  
Figure 4. Levels of leptin in periovaric adipose tissue. Data are shown +S.E.M. Post-hoc 
comparisons: *p< 0.05 (HFD vs. CD). Experimental subjects: CD/HFD, n= 6. 
• Neuroendocrine activation. A HFD strongly enhanced HPA axis activation,
overall increasing circulating levels of CORT in basal conditions (main effect of 
diet: F(1,41)= 5.795; p= 0.0207, insert Figure 5). Regardless of diet, the more 
stressful period of pregnancy was found at G16, when the plasma levels of 
CORT were seven fold higher than G18 and P1 (main effect of day: F(2,41)= 
389.157; p< 0.0001, data not shown), particularly in females fed a HFD 
(interaction between diet and day: F(2,41)= 4.664; p= 0.0150, Figure 5). 
4.3.5. Enzyme activity and gene expression 
Feeding with HFD before and during pregnancy resulted in down-regulation of 
the 11ß-HSD2 enzymatic activity in the placentas at G16 (main effect of diet: 
T14= 3.85; p= 0.0018, Figure 6A), in addition to a reduced expression of the 
placental gene 11ß-HSD1 at G18 (main effect of diet: T11= 5.416; p= 0.0002, 
Figure 6B). 
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Figure 5. Neuroendocrine activation. Basal neuroendocrine activation in dams measured both 
before (G16 and G18) and after (P1) delivery and average of basal CORT levels (insert). Data are 
shown as +S.E.M. Post-hoc comparisons: *p< 0.05 (HFD vs. CD); **p< 0.01 (G16: HFD vs. 
CD). Experimental subjects: CD-G16/G18/P1, n= 8/10/8; HFD-G16/G18/P1, n= 8/9/4. 
 
 
 
 
 
 
Figure 6. Enzymatic activity and gene expression. Activity of 11β-HSD-2 placental enzyme at 
E16 (A) and expression of 11β-HSD-1 gene in placentas at E18 (B). Data are shown as +S.E.M. 
Post-hoc comparisons: *p< 0.05; **p< 0.01 (HFD vs. CD). Experimental subjects: CD-E16/E18, 
n= 8/7; HFD-E16/E18, n= 6/8. 
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4.3.6. Locomotor activity 
A HFD significantly reduced the locomotor activity of pregnant females during 
the three days before delivery, and in particular during the central hours of the 
dark phase and soon after the onset of the light phase (interaction between diet 
and hours: F(23,299)= 2.957; p< 0.0001, Figure 7). 
 
 
 
 
Figure 7. Locomotor activity. Locomotor activity during the three day before delivery. Data are 
shown as ± S.E.M. Post-hoc comparisons: *p< 0.05 (h19: HFD vs. CD); **p< 0.01 (h12 and h13: 
HFD vs. CD). Experimental subjects: CD, n= 8; HFD, n= 7. 
 
 
4.3.7. Maternal behavioral phenotype 
• Elevated Plus Maze (EPM). HFD feeding did not affect the time spent in open 
versus closed arms (interaction between diet and zone: F(1,14)= 1.695; p= 0.2140, 
data not shown). Also, no effect of HFD was found in the percentage of entries 
into the open arms of the maze (main effect of diet: F(1,14)= 1.111; p= 0.3098, 
data not shown). Moreover, HFD females showed a reduced frequency of 
rearing in the closed arms of the apparatus (interaction between diet and zone: 
F(2,28)= 3.508; p= 0.0437, data not shown). 
• Social Avoidance Test (SAT). Regardless of diet, all pregnant dams spent 
more time in the interaction zone of the arena during both sessions (interaction 
between stimulus and zone: F(1,14)= 6.112; p= 0.0269, data not shown). Despite 
not being statistically significant (interaction between diet and zone: F(1,14)= 
2.078; p= 0.1714, Figure 8A), post-hoc comparison showed that pregnant 
females fed a HFD spent more time than CD in the interaction zone when the 
social stimulus was introduced in the wire mesh cage (post-hoc comparison for 
the % time spent in interaction zone HFD-“social stimulus” vs. HFD-“no 
stimulus”, p< 0.05). 
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• Retrieval test. While no difference was registered in the latency to retrieve the 
first pup in the nest between CD and HFD (Fisher’s exact probability test: p= 
1.000), the latter group was characterized by an increased latency to first 
sniffing a pup (main effect of diet: F(1,14)= 10.429; p= 0.0061, Figure 9A). In 
addition, females fed a HFD spent significantly more time than CD sniffing 
pups (main effect of diet: F(1,14)= 14.350; p= 0.0020, Figure 8B) and in 
grooming behavior (main effect of diet: F(1,14)= 6.133; p= 0.0266, Figure 8C). 
 
 
 
 
Figure 8. Maternal behavioral phenotype. Time (%) spent in the social interaction zone in the 
Social Avoidance test (A) and maternal behavior in the Retrieving test (B). Data are shown as 
+S.E.M. Post-hoc comparisons: *p< 0.05 (SAT: HFD-social target vs. HFD-no target), (grooming 
duration: HFD vs. CD); **p< 0.01 (sniffing pups: HFD vs. CD). Experimental subjects: CD/HFD, 
n= 8. 
 
 
4.3.8. In Situ Hybridization 
C-Fos gene expression was used as a marker of neuronal activity to assess 
neuronal activity within the sensory cortex, olfactory bulb, caudate putamen and 
paraventricular nucleus (PVN) of the hypothalamus at G16 and P1 (Table 2). 
Exposure to maternal HFD reduced c-Fos expression in the olfactory bulbs, 
which reached significance at G16 (main effect of diet: T14= 2.684; p= 0.018, 
Figure 9B). Likewise, a HFD reduced c-Fos expression in the PVN of dams 
assessed at P1 (main effect of diet: T6= 3.320; p= 0.016, Figure 9C). 
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Figure 9. Maternal behavior and olfactory bulb activity. Latency to first sniffing pups (A) and 
c-Fos expression in the olfactory bulb (B) and in the paraventricular nucleus of the hypothalamus 
(C) of dams both before (G16) and after (P1) delivery. Data are shown as +S.E.M. Post-hoc 
comparisons: *p< 0.05; **p< 0.01 (HFD vs. CD). Experimental subjects: CD/HFD, n= 8. 
Table 2. 
Table 2. C-Fos gene expression. Assessment of neuronal activity within the sensory cortex, 
olfactory bulb, caudate putamen and paraventricular nucleus (PVN) of the hypothalamus of dams 
fed a HFD or CD at G16 and P1. 
 107 
4.4. DISCUSSION 
 
Overall HFD-feeding resulted in increased levels of maternal stress hormones 
(CORT), associated to reduced 11β-HSD2 enzymatic activity and expression of 
the 11β-HSD1 gene in the placenta in addition to decreased levels of leptin in 
the adipose tissue. From a behavioral point of view, HFD dams were 
characterized by reduced exploratory activity during the active (dark) phase and 
disrupted social and maternal behavior at parturition. A highly relevant finding 
concerns the reduced neural activity in brain regions involved in olfactory 
processing and social recognition, which could underlie the inappropriate 
behavioral patterns and the cannibalism characterizing HFD-fed dams. 
Our data indicate that, despite no difference in daily food consumption, 
HFD administration for 8 weeks induced a significant gain in body weight of 
females as previously shown (Bellisario et al., 2014). Moreover, HFD dams 
were characterized by cannibalistic behavior, an event not registered in CD, and 
by an increased pup mortality rate. Interestingly, a similar increase in pups’ 
mortality rate has been registered in two separate laboratories involved in a 
collaborative study, in addition to what has been previously reported by our 
own laboratory (Bellisario et al., 2014), thus making this a highly replicable 
finding, although often under-represented in the literature. 
In this study we found that the weight of placentas collected at E18 was 
lower in HFD dams, compared to controls. This result is in line with previous 
reports from Liang and colleagues, who observed a trend of reduced placental 
weight at E19 in C57 females fed a HFD for 1 month before the breeding 
procedure, a result that these authors attributed to elevated oxidative stress due 
to the HFD (Liang et al., 2010). It is possible that a longer period of diet 
exposure, like the one used in the present study, may result in greater effects 
compared to previous reports (Liang et al., 2010). At the same stage of prenatal 
development (E18) we registered a parallel reduction in HFD fetuses’ weight. 
Several studies report reduced fetal weight with maternal obesity or 
overnutrition (Akyol et al., 2009; Hayes et al., 2012). Further, Jansson and 
colleagues demonstrated that changes in placental transport could cause altered 
fetal growth (Jansson et al., 2006). A reduction in the surface of the transporting 
epithelium in the HFD placentas might result in a decrease in the nutrient 
transport, thus reducing fetus weight.  
Interestingly, females fed a HFD were also characterized by a 
significantly extended pregnancy duration compared to CD. So far, no data are 
available about the effect of a hypercaloric diet on the duration of pregnancy. 
Nevertheless, it is possible to hypothesize that the extended pregnancy period is 
an attempt to compensate for the reduced fetal weight registered at E18, 
allowing for further fetal growth. Indeed, a strong association between maternal 
HFD-feeding before and during gestation and a lower pup birth weight was 
previously reported (Flint et al., 2005; Bellisario et al., 2014; Voltolini and 
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Petraglia, 2014). In the present study no such association was registered 
between HFD and CD pups’ weight at P1.  
In the current study we found an increased neuroendocrine response in 
female mice fed a HFD, particularly at G16, when HPA axis activation was 7-
fold higher than at G18 and P1. During pregnancy, the maternal brain triggers 
fundamentally adaptive mechanisms, allowing normal fetal development and 
protection for both mother and fetus against adverse programming during 
parturition (Voltolini and Petraglia, 2014), particularly in the days preceding 
delivery, when hormonal adaptations occur in preparation for delivery 
(Sanchez-Muniz et al., 2013). Notably, plasma CORT levels were markedly 
elevated in HFD dams at term, indicating that the effects of the diet represent a 
significant stress factor (Connor et al., 2012). An excessive level of stress 
hormones can result in a number of complications, such as intrauterine growth 
restriction, which leads to pups with reduced body weight, a condition also 
found in our study, suggesting an impairment in placental adaptive responses 
(Jackson, 2000; Sanchez-Muniz et al., 2013). These results are particularly 
interesting when considering the reduced activation of the 11 β-HSD2 enzyme 
found in the HFD placentas at G16. This enzyme is highly expressed within the 
placenta at the maternal-fetal interface and regulates fetal exposure to maternal 
glucocorticoids (Holmes et al., 2006; Cottrell et al., 2013). In placental 
mammals, cortisol/corticosterone levels in the maternal circulation are 5- to 10-
fold higher than in the fetus (Beitins et al., 1973; Dalle et al., 1978; Montano et 
al., 1991), a gradient thought to be maintained by high placental 11β-HSD2 
(Brown et al., 1993; Brown et al., 1996). This enzyme catalyses the inactivation 
of maternal glucocorticoids before they are transferred to the fetus 
(Benediktsson et al., 1997; Chapman et al., 2013; Cottrell et al., 2013). Down-
regulation of placental 11β-HSD2, in addition to being correlated with a 
significant reduction in fetal weight both in humans and rodents (Stewart et al., 
1995; Lindsay et al., 1996; Murphy et al., 2002), increases fetus vulnerability to 
the detrimental effects of maternal HFD. Indeed, in a previous study we found 
that maternal HFD programs the neuroendocrine fetal development, leading to 
greater susceptibility to stressful challenges later in life (Bellisario et al., 2014).  
Analysis of gene expression in the placenta revealed a reduced HFD-
induced expression of the 11β-HSD1 gene at E18. It is worth noticing that the 
11β-HSD1 is minimally or not expressed in fetal life until late in gestation when 
levels are greatest in organs where glucocorticoid activity is required for late 
maturation prior to birth (Staab et al., 2011). It is possible to speculate that the 
reduced expression of the 11β-HSD1 gene at that time could be associated to a 
HFD-induced impaired fetal development, further supported by the reduced 
fetal weight registered at the same time (G18). Thus, it is reasonable to state that 
maternal HFD mediates an imbalance in the expression of the genes that 
regulate the time window of fetal exposure to maternal glucocorticoids 
(Chapman et al., 2013). 
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In addition to the above mentioned results, HFD feeding strongly 
affected the maternal behavioral profile, resulting in a less explorative profile of 
pregnant females fed a HFD, as indicated by the reduced locomotor activity 
measured during the three days before delivery and the reduced frequency of 
rearing observed in the EPM on G16. Actually, it has been suggested that while 
spontaneous locomotor activity largely reflects exploratory behavior, rearing 
may also be an expression of emotionality (Gironi Carnevale et al., 1990; Thiel 
et al., 1998), suggesting that a HFD reduced emotionality of pregnant females 
resulting in a disinhibited behavior profile. Such a response has been also 
observed in the SAT. In this test, HFD pregnant females displayed reduced 
social anxiety spending more time in close proximity of the unknown CD-1 
mouse, suggesting reduced ability to discriminate an unfamiliar social stimulus. 
A similar response was also observed in the maternal behavior measured in the 
retrieving test, in which HFD dams spent more time in social investigation of 
pups (sniffing pups). These data could indicate an HFD-induced arousal towards 
social stimuli rather than increased maternal behavior. Indeed, although no 
difference in pups retrieving was registered between CD and HFD dams, the 
latter showed a greater latency to approach the pups and spent more time 
performing grooming, a displacement behavior related to negative emotions, 
such as pain and anxiety (Vos et al., 1994; Kalueff and Tuohimaa, 2005; Xu et 
al., 2008; Yao and Sessle, 2008), suggesting a lack of adaptation in such a 
context. 
One potential explanation for such changes in the behavior of the dams 
comes from our findings of reduced c-Fos expression in the olfactory bulbs of 
HFD dams both before (G16) and after delivery (P1), indicating reduced 
neuronal activation in these brain regions involved in the processing of relevant 
olfactory information (Sharp et al., 1993; Spencer and Houpt, 2001). 
Previous data have suggested that HFD, regardless of the degree of 
adiposity, can impact the neuronal structure of the olfactory system resulting in 
reduction in olfactory discrimination (Thiebaud et al., 2014). Thus in our case, a 
reduction in neural activity following HFD feeding before and during pregnancy 
might underlie significant changes in maternal behavior, suggesting that the 
cannibalistic behavior characterizing HFD dams could depend upon an inability 
to discriminate the olfactory stimuli provided by the newborn pups. 
Results also indicate reduced levels of leptin in the periovaric adipose 
tissues in HFD dams, an effect possibly associated to HFD-induced leptin 
resistance. Preclinical and clinical studies have reported HFD-induced 
hypothalamic inflammation (Cai and Liu, 2012), resulting in leptin resistance 
through activation of the negative regulators of leptin signaling (Cai and Liu, 
2012; Milanski et al., 2012). Interestingly, in the past decade, several metabolic 
markers of a nutritional status, such as leptin, have been recognized as direct 
modulators of the peripheral and central neuronal pathways involved in 
olfactory functions (Palouzier-Paulignan et al., 2012; Thiebaud et al., 2014). 
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Thus, reduced peripheral levels of leptin found in HFD-fed dams might also be 
reflected in a reduced neuronal activity of the olfactory bulb.  
It is worth noticing that the olfactory system drives behavioral decisions 
about food choice and consumption (Thiebaud et al., 2014) and the odors 
associated with food are essential to control food intake (Le Magnen, 1959). 
Therefore, a change in the activity of the olfactory system could also affect food 
choices, reinforcing inappropriate behaviors, such as the choice of poor quality 
food (Fadool et al., 2000; Lacroix et al., 2008; Tucker et al., 2013).  
Overall, results from this study indicate that HFD is a stressful 
challenge during pregnancy with relevant consequences on fetal development. 
Maternal HFD has been widely hypothesized to be one of the causes leading to 
the metabolic alteration of the offspring during life. The present study provides 
a thorough investigation on the mechanisms underlying such detrimental 
effects, suggesting that HFD can be interpreted as a stressful, metabolic 
stimulus, reinforcing neuroendocrine activation linked to parturition and 
delivery. 
More importantly, HFD-feeding also impairs the emotional profile of 
pregnant dams and the neural activity of brain regions involved in the 
development of maternal behavior with aberrant consequences on the offspring 
(Cirulli et al., 2003). 
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5. GENERAL DISCUSSION 
 
Maternal obesity and HFD consumption during pregnancy have profound 
effects on offspring health, ranging from metabolic to behavioral disorders in 
later life, although a comprehensive characterization of the long-term impact of 
the maternal-mediated metabolic stimulus is still lacking. The objectives of the 
studies described in this thesis were 1) to explore the impact of prenatal 
exposure to maternal HFD on the behavioral, endocrine and metabolic 
phenotype of the adult offspring and 2) to investigate if HFD feeding during 
pregnancy might represent a metabolic stressful stimulus for the mother. To 
this aim the impact of exposure to HFD was evaluated both on fetal 
development - in a long-term perspective- as well as on maternal behavior and 
physiology in a mouse model of reduced OS (the p66Shc-/- mouse). In this 
context a main emphasis was given to the interaction between this metabolic 
stressful stimulus (maternal HFD) and a physiological condition of reduced OS 
in the offspring in both genders. 
 
5.1. MAIN FINDINGS 
 
5.1.1. Maternal HFD acts as a psychophysical stress affecting offspring 
physiology in a lifelong, gender-dependent fashion 
Early life experiences, including the prenatal fetal development, are an 
important programming factor on a number of aspects of the offspring’s 
physiology, representing a risk factor possibly impairing a proper metabolic and 
neuroendocrine function and also affecting the emotional and behavioral profile 
of the individual in a lifelong perspective (Spencer, 2013). In this regard, early 
life stress, as well as extreme metabolic conditions, such as prenatal exposure to 
a maternal diet highly rich in fats, can deeply influence developmental 
programming. In fact, preclinical studies have shown that changes in maternal 
diet also influence the response to stress with relevant consequences on the 
offspring, including adverse behavioral changes (Weinstock, 2001), 
cardiovascular responses to stress (Igosheva et al., 2007), glucose tolerance 
(Lesage et al., 2004), as well as sexual dimorphism of brain regions. This latter 
point suggests that there might be gender-dependent differences in the risk for 
metabolic and mood disorders associated to maternal HFD in utero as shown in 
the adult population.  
Previous preclinical studies have reported increased anxiety-like 
behavior in adult subjects of both genders exposed to HFD during fetal 
development (Peleg-Raibstein et al., 2012), although in some cases a gender 
dependent effect is reported (Bilbo and Tsang, 2010). Results described in 
Chapter 2 are in line with the latter finding, reporting that female subjects 
exposed to maternal HFD during prenatal life show a reduced emotional profile 
compared to male mice. In addition, and more interestingly, prenatal HFD 
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drives an inversion in the emotional profile if compared to that observed in CD 
offspring. More in detail, prenatal HFD reduces the anxiety-like behavior in 
female while increasing it in males, suggesting a feminization of the emotional 
profile of male mice. This is particularly interesting in light of the results 
obtained by Weinstock and colleagues in a rat model of prenatal stress  that 
observed a similarfeminization effect in male subjects (Weinstock, 2001), 
suggesting that prenatal metabolic alterations act as psychophysical stressful 
stimuli with potential implications for brain function. This latter point is further 
corroborated by results related to the HPA-axis activation of the adult offspring 
after an acute psychophysical stress. In particular, while no difference in the 
neuroendocrine activity was observed in male mice, females prenatally exposed 
to HFD showed an overall significantly increased response to an acute restraint 
stress, as a result of an impairment of the negative feedback of the HPA axis. It 
is worth noticing that the alterations of the neuroendocrine profile induced by 
maternal HFD largly overlap with those observed in animal models of prenatal 
stress. For instance, Louvart and colleagues reported that female offspring of rat 
dams exposed to a chronic restraint stress during the last trimester of pregnancy 
display, at adulthood, a stronger response to restraint stress (Louvart et al., 
2009). In this context it is possible to hypothesize that a metabolic challenge 
(maternal HFD) could mimic a psychophysical stress, as both interfere with the 
fetal programming of neuroendocrine development, altering the HPA axis 
activity during the entire life span (Maccari et al., 2003; Seckl and Holmes, 
2007; Reynolds et al., 2013; Spencer, 2013). One potential explanation for how 
stressful and nutritional challenges occurring during the prenatal life can 
influence the neuroendocrine mechanisms in a long-term perspective is that they 
can permanently alter the sensitivity of the HPA axis and thus the overall levels 
of GC the animal is exposed to (Spencer, 2013). 
A gender-dependent effect of maternal diet was found in response to 
metabolic stimuli. Several data have been reported on differences between 
genders in the perception of metabolic signals (Lonnqvist et al., 1997). This 
point deserves further investigation since it could contribute to understanding 
the observed differences in the prevalence rates of eating disorders and obesity 
between genders (Kaye, 2008). The study described in Chapter 2 refers to an 
overall increase in glucose tolerance in females prenatally exposed to HFD, 
suggesting a better ability to metabolize the excess of blood glucose, while an 
opposite profile was found in males, in which HFD determined greater glucose 
intolerance. 
Moreover, the studies presented in Chapter 2 provide new insights into 
the critical role that early life environment plays in programming the subsequent 
responses to stress and feeding behavior. In particular, it is worth noticing that 
high-fat feeding during pregnancy, independently from maternal obesity, causes 
per se placental dysfunctions in the mother as well as metabolic impairments in 
the offspring (McCurdy et al., 2009; Frias et al., 2011). In addition, since the 
early life environment has also a specific influence on brain development and 
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circuitry, stress and the early life nutritional environment can acutely affect the 
connectivity within the hypothalamic region necessary for regulating feeding 
leading to a long-term abnormal foraging behavior. 
Overall, these results strongly point to the prenatal environment as a 
main developmental sensitive period. This time window appears to be  equally, 
if not more, important than other sensitive developmental steps, such as 
lactation and adolescence, in programming the individual 
vulnerability/responsivity to stress, nutritional needs and feeding behavior and, 
more importantly, how stress and metabolic needs might influence one another. 
Therefore early life environment may at least in part account for these inter-
individual differences.  
 
5.1.2. Reduced oxidative stress characterizing the p66Shc-/- mouse thwarts 
the effects of prenatal exposure to maternal HFD 
Previous findings reported that functionality loss of the p66Shc gene in mice 
protects from the negative effects induced by adult exposure to HFD - including 
adiposity and IR - through multiple mechanisms, also comprising reduction of 
systemic OS (Frankel and Rogina, 2012).  
Chapter 2 describes the multi-level protective role played by p66Shc-/- 
gene after maternal exposure to HFD. Such a role is observed both in the 
mother during the last phases of pregnancy and during parturition as well as in 
the adult offspring, particularly as concerns the metabolic and the 
neuroendocrine profile.  
HFD-feeding is associated to increased mortality rate of pups, due to 
impaired maternal behavior. Very intriguingly, an increased mortality rate was 
also observed in HFD dams during the days immediately before the expected 
delivery date or during parturition. Similar findings were previously reported by 
Flint and co-workers, further corroborating the critical role played by maternal 
diet in such time window (Siemelink et al., 2002; Buckley et al., 2005; Flint et 
al., 2005). However, in this context, the lack of the p66Shc gene plays a 
protective role, at least for selected parameters such as dams’ mortality and 
aberrant maternal behavior, which, in turn, results in cannibalistic behavior.  
Moreover, in Chapter 2 it is well described the protective action of 
reduced OS characterizing the p66Shc-/- mice on the metabolic and 
neuroendocrine negative effects of the early exposure to maternal HFD. Also in 
this case, as previously briefly mentioned a strong gender-dependent effect was 
found as a result of gene deletion.  
As far as the metabolic challenges are concerned, the lack of the p66Shc 
gene was able to modulate the response to metabolic stimuli, resulting in a 
greater resistance towards a glucose challenge, compared to WTs. Such effect is 
affected by the diet in a gender-dependent fashion. Indeed, in KO females, 
prenatal exposure to HFD drove a higher glucose tolerance resulting in a better 
ability to metabolize an excess of blood glucose, while in KO males an opposite 
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profile was found, with HFD determining severe glucose intolerance in 
comparison to controls (CD-KO). In the light of these points, it is reasonable to 
hypothesize that HFD overrides the effects of the lack of p66 gene on 
metabolism in males, reducing the glucose resistance, and exacerbating it in 
females.  
Lack of the p66Shc gene leads to greater resistance in the IST test. 
Resilience to an insulin challenge is affected not only by the genotype, but also 
by the maternal diet, since HFD individuals showed greater insulin insensitivity. 
In particular, Turdi and co-workers suggested that such IR could result from a 
severely dampened insulin-signaling-cascade (Turdi et al., 2013). Thus, the 
metabolic alterations described in KO mice might be due to the reported 
involvement of p66Shc gene in the insulin signaling (Berniakovich et al., 2008), 
which leads to hypothesize that its deletion results in insulin desensitization 
with the consequent impairment in glucose metabolism. 
Another main finding, which highlights the protective role exerted by 
the lack of the p66 gene, is related to the programming effect of HFD on the 
neuroendocrine development and responsiveness later in life. More in detail,  in 
female mice, HFD significantly increases the response to an acute restraint 
stress, however KO subjects are protected from such effect, showing an 
efficient HPA axis feedback that is comparable/specular to thatobserved in 
controls (Chapter 2). There is a great body of evidence suggesting that HFD 
consumption is strongly associated to an increased condition of general 
inflammation (Contestabile, 2001) It is important to note that in vitro studies 
have shown that increased ROS generated upon inflammatory challenges, , may 
attenuate the GC negative feedback suggesting that neuroendocrine function 
may be finely modulated upon OS/inflammatory signaling pathways (Okamoto 
et al., 1999; Asaba et al., 2004). 
 
5.1.3. Antioxidants mimic the metabolic response of the p66Shc-/- gene 
following prenatal exposure to HFD 
Increasingly experimental and clinical data suggest that antioxidants have a 
beneficial role in the prevention of metabolic disorders, such as IR (Masha et 
al., 2009; Novelli et al., 2009). N-acetyl-cysteine (NAC) is an interesting target 
because of its antioxidant and anti-inflammatory effects. Indeed, NAC has been 
recently shown to exert a protective effect against some metabolic disorders in 
rats (Haber et al., 2003; Song et al., 2005; Diniz et al., 2006; Novelli et al., 
2009). In these studies, it has been found that NAC supplementation is able to 
prevent hyperglycemia and glucose intolerance associated with the preservation 
of glucose-induced insulin secretion and improved insulin sensitivity. It is 
relevant to note that these data are also confirmed by a very recent study 
conducted by Lasram and colleagues (Lasram et al., 2014).  
Interestingly, in line with literature data, results obtained in Chapter 3 
describe that male mice prenatally exposed to NAC show a greater resistance 
 125 
toward a glucose challenge compared to untreated controls. However, such 
effect is lost in males prenatally exposed to maternal HFD, showing a severe 
glucose intolerance in comparison with their own controls (NAC-CD), 
suggesting that prenatal exposure to NAC is not completely able to counteract 
the negative metabolic effect driven by maternal HFD. 
However, results related to the effects of NAC on the metabolic 
response to insulin, reported in Chapter 3, do not agree with literature data. 
Indeed, while several studies reported greater NAC-induced insulin sensitivity, 
we found that prenatal NAC exacerbated insulin resistance characterizing HFD 
male mice. 
The mechanism by which NAC affects the metabolic response to 
glucose and insulin is not yet completely understood. NAC promotes the 
synthesis of growth stimulating hormone (GSH) (Song et al., 2005), which has 
been found to have cellular functions unrelated to its antioxidant activity, such 
as acting on several signaling pathways. The few studies performed so far lead 
to hypothesize that the effects of NAC on glucose homeostasis are mediated by 
the increase of hepatic GSH output, which in turn positively affects body red-ox 
status and early events of the insulin signaling pathway, mainly by a reduction 
of OS. 
The described mechanism of action of NAC drug appears supported by 
the evidence that the metabolic profile induced by a glucose challenge is strictly 
similar in NAC subjects and in p66Shc-/- mice, in particular in male mice (see 
Chapter 2, paragraph 3.5 and Chapter 3, paragraph 5.4). 
Similarly, in the insulin sensitivity test a comparable action between the 
NAC drug and the lack of the p66Shc gene has been registered. This is shown by 
the glycemic trend of NAC subjects in response to the insulin stimulus that 
perfectly follows that characterizing the genetic model of reduced OS. This 
evidence strongly suggests that the effect of prenatal NAC mimics the lack of 
p66Shc gene on the metabolic profile. It is possible to hypothesize that this effect 
is due to the parallel exposure of the developing fetus to both stimuli, i.e. 
maternal HFD and NAC, which might have rendered the antioxidant action 
more efficient in an attempt to reduce the HFD-induced fetal misprogramming. 
In addition, Goodson and co-workers assessed NAC effectiveness as a 
chemotherapic agent, finally suggesting that NAC may be more useful as a 
chemopreventive agent in the context of acute UV exposure (Goodson et al., 
2009). The preventive action against the UV-induced oxidative stress, 
demonstrated by Goodson and co-workers, is ascribable to the potent 
antioxidant capacity of NAC (Goodson et al., 2009). Similarly, from the study 
described in Chapter 3 emerges that the effects of NAC on the metabolic 
response are mainly ascribable to the precocious time window of exposure, 
allowing for a preventive pharmacological action of the drug. 
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5.1.4. HFD during pregnancy is a stressful challenge resulting in aberrant 
maternal behavior and impaired neuronal activity 
The mechanisms by which prenatal stress alters later life metabolic outcome 
remain unknown. Stress during pregnancy alters maternal hormones, including 
circulating GCs levels. Normal physiological levels of GCs during fetal 
development are essential for tissue growth and maturation, however, when they 
exceed, GCs have been shown to affect negatively maturation of tissues and 
organs (Bian et al., 1992; Fowden, 1995). Elevated maternal GCs can cross the 
placenta (Cottrell et al., 2012) and this has been shown to affect growth and 
function of brain and peripheral tissues during fetal development (Duthie and 
Reynolds, 2013). Exposure to increased level of GCs either through 
administration of dexamethasone during late gestation or via stress exposure 
(malnutrition, adverse environment exposures) reduces birth weight and impacts 
maturation of major organs (Lesage et al., 2001; Seckl, 2004). Dams exposed to 
prenatal variable stress had heavier adrenal mass and lower fecal CORT 
secretion vs. non-stressed controls (Paternain et al., 2012). This is suggestive of 
a reduced CORT clearance in these stressed dams during gestation.  
In line with literature data, results in Chapter 4 describe an increased 
neuroendocrine activity characterizing female mice fed a HFD, particularly at 
G16, when HPA axis activation is 7-fold higher than at G18 and P1. During 
pregnancy, maternal brain triggers adaptive mechanisms allowing normal fetal 
development and protection for both mother and fetus against adverse 
programming (Voltolini and Petraglia, 2014). This particularly happens in the 
days preceding delivery, when hormonal adaptations occur in preparation for 
delivery (Sanchez-Muniz et al., 2013). Notably, plasma CORT levels are 
markedly elevated in HFD dams at term, indicating that the effects of the diet 
represent a significant stress factor (Connor et al., 2012). An excessive level of 
stress hormones can result in a number of complications, such as intrauterine 
growth restriction, which leads to pups with reduced body weight, a condition 
also found in our study, possibly suggesting an impairment in placental adaptive 
responses (Jackson, 2000; Sanchez-Muniz et al., 2013).  
These results are particularly interesting when considering the reduced 
HFD-induced activity of the 11β-HSD2 enzyme at E16, in addition to the 
reduced expression of the 11β-HSD1 gene at E18. These specific placental 
enzymes protect fetus from high GCs levels, acting as a placental barrier, which 
regulates the transfer of GCs from mother to fetus (Benediktsson et al., 1997; 
Holmes et al., 2006). Stocker and colleagues reported that likely, as with 
maternal stress, maternal nutrition regulates placental 11β-HSD2 levels, in turn, 
influencing fetal exposure to GCs (Stocker et al., 2004; Stocker et al., 2005). 
Thus, results of the study might suggest that HFD compromises the timing of 
the switch from 11β-HSD type 2, in early and mid-gestation (Murphy, 1978; 
Brown et al., 1996; Condon et al., 1998), to 11 β-HSD type 1 activity, in late 
gestation (Murphy, 1978; Thompson et al., 2004), functional to a correct fetal 
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development. In addition, it is possible speculate that the reduced expression of 
the 11β-HSD1 gene at E18 could be associated to a HFD-induced impaired fetal 
development, an hypothesis further supported by the reduced fetal weight 
registered at the same time. An HFD-mediated imbalance in the expression of 
the genes regulating the time window of fetal exposure to maternal GCs 
(Chapman et al., 2013) has been reported to have a number of effects, 
interfering with synaptic pruning during brain development in regions that are 
important for the control of the HPA axis, the prefrontal cortex and 
hippocampus (Jacobson and Sapolsky, 1991; Spencer et al., 2005). 
A relevant result reported both in Chapters 2 and 3 is the increased 
mortality rate of pups from HFD-fed dams as a result of cannibalistic events. 
This observation was not previously reported in literature. These evidences lead 
us to hypothesize that this event might be associated to an HFD-induced 
impairment in maternal behavior.  
In the attempt to find a neurobiological support to the behavioral 
observation, in the study described in Chapter 4, in addition to maternal 
behavior, the c-Fos expression in several brain areas was also measured. It is 
usually assumed that c-Fos expression provides a reliable marker of neuronal 
activation (Sharp et al., 1993; Spencer and Houpt, 2001). Particular attention 
has been paid to the olfactory bulbs, a brain region involved in the identification 
of olfactory stimuli and particularly relevant in a macrosmatic species, like the 
mouse. Results reported in Chapter 4 do not register differences in pups 
retrieving between CD and HFD dams; however the latter group showed a 
greater latency to approach the pups, another reliable index of reduced maternal 
behavior. This data seems to confirm the hypothesis that HFD during pregnancy 
might impair the development of maternal behavior.  
In addition to maternal behavior, HFD strongly affected the explorative 
and emotional profile of pregnant females. HFD feeding resulted in a less 
explorative profile, as indicated by the reduced locomotor activity measured 
during the three days before delivery and the reduced frequency of explorative 
behavior (rearing) observed in the EPM on G16. Previous studies suggested 
that rearing may also be a behavioral index of emotionality (Gironi Carnevale 
et al., 1990; Thiel et al., 1998), thus suggesting that HFD reduced emotionality 
of pregnant females resulting in a disinhibited behavior profile. This is further 
confirmed by the behavioral profile observed in the SAT, in which HFD 
pregnant females displayed reduced social anxiety spending more time in close 
proximity of the unknown CD-1 mouse, but also suggesting a reduced ability to 
discriminate an unfamiliar social stimulus. 
A potential explanation for such changes in the behavior of the dams 
comes from our findings of reduced c-Fos expression in the olfactory bulbs of 
HFD dams both before (G16) and after delivery (P1), indicating reduced 
neuronal activity in those brain regions involved in the processing of relevant 
olfactory information (Sharp et al., 1993; Spencer and Houpt, 2001). Taken 
together, these results demonstrate complex interactions between the nutritional 
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status of an animal and its behavioral and neuronal olfactory bulb responses to 
odor stimuli. Our results also indicate a modulating role of nutritional status, 
that is HFD, on c-Fos olfactory bulb responses to olfactory stimuli, as 
previously suggested (Thiebaud et al., 2014). 
5.2. IMPACT AND PERSPECTIVES 
Due to the epidemic proportion of obesity and overweight (Hurt et al., 2010), 
and the related healthy consequences, and taking into account its increasing 
incidence among children and pregnant woman, in addition to the adult 
population, (Mitchell and Shaw, 2014) the evaluation of physiological 
adaptation to diets rich in fats, ranging from behavioral to hormonal and 
molecular endpoints, has stimulated the scientific interest in several fields.  
Growing evidence suggests that maternal obesity increases the risk of 
childhood obesity and subsequent adult disease. Many studies have reported 
higher incidences of obesity and several metabolic disturbances, such as 
hyperglycemia as well as IR and T2D as a result of prolonged high-fat feeding 
(Oakes et al., 1997; Tschop and Heiman, 2001; Buettner et al., 2007). More 
importantly, such phenomenon not only directly affects the HFD-consuming 
individuals but also predisposes subsequent generations to similar health 
concerns. There is therefore a real and immediate need for interventions that 
target the development of offspring obesity.  
Human studies have identified maternal risk factors associated with 
disturbed offspring health, such as gestational weight gain, elevated adiposity, 
hyperglycaemia and IR. These outcomes provide key targets for interventions 
that seek to improve offspring health. Recent evidence suggests that altering 
maternal carbohydrate and/or physical activity levels can improve maternal 
pregnancy outcomes. Indeed, pregnant women are an extremely susceptible 
population, given their higher nutritional demands both in quantity and in 
quality terms. Inappropriate nutrient supply during this critical period of time 
inevitably results in an early onset of chronic diseases in the future generations. 
Therefore, a better understanding of the physiological origin of HFD-related 
effects will not only benefit the success of conception but also protect the 
progeny against unfavorable environmental challenges. 
Alhtough longitudinal studies adequately describing the long-term 
impact of these early metabolic interventions on offspring health are lacking,, 
basic research provides us highly valuable information that might allow 
translational applicability in the clinical field. Increasing evidence supported by 
a substantial amount of animal studies has indeed demonstrated that pre- and 
peri-natal exposure to HFD profoundly alters the intrauterine environment 
leading to permanent phenotypic alterations with adverse outcomes that persist 
through the adulthood of the progeny. Compromised nutritional environment 
during early development stages targets both immediate health problems in 
newborns and continuing consequences in adulthood. These outcomes manifest 
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at certain physiological levels including metabolism, emotional disturbances 
and learning ability, endocrine alterations and susceptibility to chronic diseases 
(Napoli et al., 2002; Srinivasan et al., 2006; Elahi et al., 2009).  
It is relevant to note that human studies are limited mainly by the 
restrictions to invasive methodologies in offspring. Animal models therefore 
provide an alternative in which interventions that seek to protect offspring from 
a conferred obesity risk may be investigated. Animal studies reported in this 
thesis provide a great clinical value, allowing early prevention and development 
of therapeutic treatment.  
This thesis was mainly focused on a maternal model of HFD, in which 
the diet was given to the dams both before and during gestation in order to 
investigate the transgenerational impact of maternal feeding patterns on fetal 
outcomes. Fat overconsumption prior to or during pregnancy results in an 
unfriendly intrauterine environment, on which the concentrations of energy, 
hormones and blood supply are less optimized and, not surprisingly, leads to 
abnormal fetal development and growth (Srinivasan et al., 2006; Chen and 
Scholl, 2008; Samuelsson et al., 2008; McCurdy et al., 2009; Bilbo and Tsang, 
2010).  
Taken together, data presented in this thesis are consistent with the 
hypothesis of an early obesogenic nutritional “hit” and a developmental origin 
of sex-dependent susceptibilities for the HFD exposure-related consequences. 
The placenta might play a crucial role in mediating such effects to the fetus and 
offspring. Previous studies report that feeding C57BL/6J mice a HFD during 
pregnancy leads to modified expression of imprinted genes and local or 
genome-wide DNA methylation in placenta and that these effects are sex-
specific (Gallou-Kabani et al., 2010; Mao et al., 2010). It is possible to 
speculate that the sex-dimorphic differences we observed in the adult offspring 
may represent the consequence and transgenerational fixation of detrimental 
dietary exposures on the placenta during the early prenatal period. In humans, 
this would correspond to the commonly encountered gestational conditions of 
overweight or milder forms of obesity. Due to the lack of evidence on long-term 
health outcomes, those conditions have not yet been included in recent clinical 
guidelines for preventive action to ameliorate obesity in adults or specifically in 
women of fertile age (Moyer, 2012). Nonetheless, at least in our rodent model, 
such a nutritional environment during the earliest phases of development is 
sufficient to induce long-term adverse effects in offspring phenotypic outcomes. 
This indicates varying developmental vulnerabilities between sexes towards 
overnutrition. 
More importantly, data reported in this thesis indicate that not only 
obesity, but also the consumption of diet rich in fats and sugars per se has 
relevant consequences for the health outcomes of both mother and offspring. 
The negative effects of wrong dietary habits, which might result in unhealthy 
metabolic condition such as IR and diabetes, often are not accompained with a 
gain in body weight or any relevant symptom. The metabolic disturbancies, 
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which might firstly develop through an asymptomatic phase, might thereafter 
become evident when conclamate pathologies. In this prospective a preventive 
intervention is the only way to walk. A sensitization to the multi-levels health 
consequences deriving from wrong dietary habits and, more in general, wrong 
lifestyle should be promoted in order to guide people toward an informed 
nutritional behavior.  
Several studies have reported a causative link between HFD feeding and 
nervous system dysfunction and perturbed neuronal plasticity (Park et al., 2010; 
Pierce and Xu, 2010; McNay et al., 2012; Yi et al., 2012). As also reported in 
Chapter 4, HFD-feeding has been found induce lower neuronal activity in 
several brain area and particularly in the olfactory bulb, the main brain system 
driving behavioral decisions about food choice and consumption (Thiebaud et 
al., 2014). The odors associated with food are essential to control food intake 
(Le Magnen, 1959). Therefore, HFD-induced changes in the activity of the 
olfactory system might affect food choices thus reinforcing inappropriate 
behaviors, such as the choice of poor quality food (Fadool et al., 2000; Lacroix 
et al., 2008; Tucker et al., 2013). The trigger of this vicious cycle might be 
relevant as well as detrimental implication for health. 
One of the most relevant finding of this thesis is that HFD experienced 
during pregnancy represents a potential physiological stressor for dams. This 
effect is demonstrated by the increased HPA-activity characterizing HFD 
pregnant dams and is further supported by the aberrant maternal behavior 
observed after delivery. Despite the paucity of literature data regarding the 
effect of HFD on both HPA-axis activity during pregnancy and maternal 
behavior, data obtained in this thesis concordantly support this hypothesis. 
Importantly, our results acquire a major relevance taking into account 
the several clinical studies supporting the stressful role played by diets rich in 
fats in women during pregnancy (McCurdy et al., 2009; Frias et al., 2011; 
Reynolds et al., 2013).  
This observation drives a raising attention on the negative role played 
by HFD, and more in general by unhealthy diets, not only on metabolism and 
on related-pathologies both in the mother and in the offspring, but in a more 
wide prospective on the psycho-physiological outcome and on the behavioral 
and emotional profile of mothers which is directly reflected on the offspring. 
Thus, in addition to maternal interventions, focus can be placed on 
offspring outcomes associated with obesity development, metabolic-related 
pathologies and psychological disorders. To date, there is a paucity of studies 
investigating potential intervention strategies in either over-nourished mothers 
or in their offspring that aim to attenuate offspring predisposition to these 
disorders. Addressing such possibilities is therefore an important research need. 
These should include targeting maternal parameters associated with excess 
nutrition and/or obesity (hyperglycaemia, hyperlipidaemia, hyperinsulinaemia 
and increased stress and inflammatory markers), as well as the phenotypic 
consequences in the offspring (hyperphagia and reduced physical activity). 
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Results may then help to combat the cycle of maternal obesity and offspring 
obesity. 
 
5.2.1. Intervention strategies 
Results obtained and discussed in Chapter 3 describe the potential effect of a 
synthetic antioxidant administered during the prenatal life, that is NAC, to limit 
some of the long-term consequences deriving from prenatal exposure to 
maternal-HFD. However, prenatal exposure to NAC is not completely able to 
counteract the negative metabolic effect driven by maternal HFD. This finding 
suggests that a long-lasting rather than a short-term pharmacological 
intervention could be resolutive to prevent and thwart metabolic disturbances. 
However, given the expense and potential long-term risks of 
pharmacological therapies, lifestyle interventions have also to be seriously 
considered as a viable alternative. Lifestyle, such as healthy diet and physical 
exercise, can be useful in the prevention and treatment of obesity and metabolic 
disorders.  
Prevention strategies rather than treatment have gained newfound 
interest, particularly with the increasing incidence of obesity and risk of 
attendant complications in developing countries. Having obese women lose 
weight and achieve a normal BMI prior to conception would be the ideal goal, 
but realistically quite difficult to achieve, given the known problems of 
achieving optimal glucose control in women planning to become pregnant. 
Treatment modalities such as minimization of weight gained during pregnancy, 
combined with the institution of healthy eating and exercise regimens, may 
represent an ideal option for these interventions.  
This kind of intervention should also have an evident positive economic 
impact not only for the individual, but in a more wide perspective, for the 
Public Health System allowing a great cost reduction.  
 
5.2.2. Impact and relevance of the p66Shc gene 
The p66Shc gene appears to be one of the converging points linking OS, 
metabolism and the genetics of ageing, its lack of functionality leading to a 
plethora of positive effects, accounting for retarded aging, in addition to a more 
general healthier status (Berry et al., 2007; Berry et al., 2008; Berry et al., 
2010). Overall the “thrifty function” of p66Shc appears desirable when food is 
scarce and resources need to be stored. However, fat accumulation promoted by 
p66Shc can be detrimental when food is constantly available - a condition 
characterizing westernized lifestyle - and may lead to increased vulnerability to 
develop degenerative diseases such as diabetes, CVD and cancer, accelerating 
the aging process (Neel, 1962; Neel et al., 1998). Being at the crossroad of 
signaling pathways involved in both central and peripheral stress responses and 
in the regulation of energy homeostasis, p66Shc is a good candidate molecule to 
address the mechanisms underlying healthy phenotype and to be targeted for the 
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development of novel pharmacological tools for the prevention or cure of 
metabolism-related pathologies.  
Future studies should address the issue of the cause-effect involvement 
of p66Shc in metabolic-related disorders. In addition, the assessment of changes 
in the p66Shc expression early in life might represent a sensitive marker allowing 
the detection of early changes in the metabolic/health status in humans. 
Therefore, p66Shc should be potentially used in clinical practice as specific 
peripheral biomarkers of a pathological metabolic state indicating a potential 
risk not only for metabolic disorders but, given the pivotal role played in the 
red-ox cellular processes, even and importantly for age-related pathologies and 
the associated disorders. 
Finally, data discussed in this thesis set the conditions for future studies 
aimed at better understanding the role of p66Shc in the adaptive response to 
metabolic stressors in order to develop novel diagnostic and therapeutic tools 
aimed at promoting healthy phenotype mainly in an aging perspective.  
5.3. CONCLUSIONS 
There has been a significant increase in the prevalence of obesity in the past 
decades both in developed and in developing countries. This increased 
prevalence is not confined to adults only, but is beginning to affect even youth, 
having been reported with increasing frequency in adolescents and children as 
young as 2 years of age. Although there is significant morbidity and mortality 
associated with obesity in and of itself, there are additional risks associated with 
the metabolic syndrome, which is a component of and may in itself be a 
consequence of obesity.  
The early nutritional environment is thought to be a major determinant 
to the development of obesity in the young and adult offspring. Moreover, the 
exposure to particular diets during critical early periods, e.g., during pregnancy, 
might result in subjects that are exceptionally vulnerable to environmental 
factors that contribute to obesity (Delisle, 2005).  
It is clear that maternal HFD has a profound influence on the response 
of the offspring, in both the periphery and the brain, affecting not only 
physiological phenotype (metabolic and endocrine), but also the behavioral 
profile. These effects can have enduring consequences for brain functioning and 
the onset of neurodegenerative disorders, affecting both males and females, 
often with different outcomes. The perinatal period is a crucial time when 
adverse experiences have a major impact on developing systems and neuronal 
and HPA axis activity are critical in mediating the influence of the environment 
on the individual. In an ontogenetic perspective, a novel concept to be explored 
is how the quality and quantity of different early experiences affect neural, 
endocrine, metabolic and behavioral domains relevant across diverse disorders, 
ranging from mental health to neurodegeneration and obesity. Such wide range 
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of effects may explain the co-morbidity often found between different 
pathologies, which can greatly affect quality and even longevity of life.  
Knowledge on specific measures capable to alleviate fetal overgrowth 
in obese pregnant women can allow the development of early intervention 
strategies that could contribute to a decrease in the prevalence of obesity and 
diabetes, and more in general of metabolic disorders, in future generations. 
Additional studies are needed to establish the critical time window during 
perinatal development when HFD exposure influences the behavioral and neural 
responses observed in this study. Determining how maternal HFD specifically 
affects brain signaling pathways in offspring will allow a more time-selective 
targeting of interventions to counteract the consequences of overnutrition on 
developmental programming. 
Another relevant contribution of these studies, which should inform 
future research, is the knowledge that metabolic stimuli can act as stressors, 
potentially affecting the neuroendocrine system, with greater effects if 
experienced during critical developmental periods. This point is worth taking 
into account, given the emergency of obesity and the world widespread 
consumption of high fat food, independently from obesity. 
Several studies have shown that administration of high fat or high 
calorie diets to rodents increases the cellular oxidative state (Zhang et al., 2005; 
Souza et al., 2007), thus also resulting in increased oxidative damage in the 
brain (Cecarini et al., 2007; Bruce-Keller et al., 2009; Zhang et al., 2009). In 
turn, increased OS mediates the effects of HFD consumption both on brain 
pathogenesis and cognitive disturbances and exacerbates HFD-related metabolic 
impairment.  
The p66Shc-/- mouse is a valid model of reduced OS (Trinei et al., 2009) 
interestingly characterized, among several other features, by reduced 
trygliceride accumulation, increased metabolic rate, decreased fat mass and 
resistance to diet-induced obesity (Berniakovich et al., 2008; Tomilov et al., 
2011). This cluster of combined characteristics represents a stimulus for the 
growing interest in the study of the relationship between maternal HFD and OS 
and its effect on the offspring.  
Finally, all these processes, which also interact with the genetic 
background of the individual, can lead to epigenetic changes participating to 
long-term effects of early life experiences and thus offer a platform for 
environmental and/or pharmacological intervention. 
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